Page last updated: 2024-12-04

bmy 7378

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID210172
CHEMBL ID543741
SCHEMBL ID987183
MeSH IDM0151373
PubMed CID2419
CHEMBL ID13647
CHEBI ID92539
SCHEMBL ID6017145
MeSH IDM0151373

Synonyms (98)

Synonym
EU-0100206
bmy 7378 dihydrochloride, >=98% (hplc), solid
1,1-cyclopentanediacetimide, n-(2-(4-(o-methoxyphenyl)-1-piperazinyl)ethyl)-, dihydrochloride
n-(2-(4-(o-methoxyphenyl)-1-piperazinyl)ethyl)-1,1-cyclopentanediacetimide dihydrochloride
bmy7378
bmy 7378 dihydrochloride
NCGC00093679-01
bmy 7378 ,
B-134
azaspiro[4.5]decane-7,9-dione dihydrochloride
8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl-
21102-95-4
chembl543741 ,
8-[2-[4-(methoxyphenyl)-1-piperazinyl]ethyl]-8- azaspiro[4.5]decane-7,9-dione dihydrochloride;bmy 7378
A25032
8-(2-(4-(2-methoxyphenyl)piperazin-1-yl)ethyl)-8-azaspiro[4.5]decane-7,9-dione dihydrochloride
unii-kc07kv8t5o
kc07kv8t5o ,
AKOS015999114
LP00206
8-azaspiro(4.5)decane-7,9-dione, 8-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-, dihydrochloride
S2691
CCG-221510
MG-0114
NCGC00260891-01
tox21_500206
SCHEMBL987183
8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl-8-azaspiro[4.5]decane-7,9-dione dihydrochloride
8-[2-[4-(methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione dihydrochloride
HB2136
c17h17cln4
8-chloro-11-(1-piperazinyl)-5h-dibe nzo[b,e][1,4]diazepine
AC-26868
DTXSID10175334
bmy7378 hcl
J-013847
SR-01000075542-3
SR-01000075542-1
sr-01000075542
SW219365-1
bmy 7378 2hcl
FT-0710084
8-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-8-azaspiro[4.5]decane-7,9-dione;dihydrochloride
Q27894467
8-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-8-azaspiro[4.5]decane-7,9-dione 2hcl
BCP02522
EX-A2035
C74006
WAA10295
HY-100554
CS-0019699
8-(2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl)-8-azaspiro[4.5]decane-7,9-dione
BRD-K31054881-300-01-3
gtpl9
NCGC00024935-01
tocris-1006
lopac-b-134
NCGC00015126-01
LOPAC0_000206
NCGC00024935-03
NCGC00024935-02
8-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-8-azaspiro(4.5)decane-7,9-dione
bmy-7378
8-azaspiro(4.5)decane-7,9-dione, 8-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-
21102-94-3
NCGC00015126-06
L000137
CHEMBL13647 ,
8-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-8-azaspiro[4.5]decane-7,9-dione
8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione
8-{2-[4-(2-methoxy-phenyl)-piperazin-1-yl]-ethyl}-8-aza-spiro[4.5]decane-7,9-dione
8-(2-(4-(2-methoxyphenyl)piperazin-1-yl)ethyl)-8-azaspiro[4.5]decane-7,9-dione
bdbm50026917
8-{2-[4-(2-methoxy-phenyl)-piperazin-1-yl]-ethyl}-8-aza-spiro[4.5]decane-7,9-dione(bmy-7378)
BCP9000439
CCG-204301
unii-08ei0k81ol
08ei0k81ol ,
NCGC00015126-02
NCGC00015126-03
NCGC00015126-05
NCGC00015126-04
BCPP000322
bmy-7378 free base
SCHEMBL6017145
AYYCFGDXLUPJAQ-UHFFFAOYSA-N
CHEBI:92539
NCGC00015126-08
Q4836102
8-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}-8-azaspiro[4.5]decane-7,9-dione
DTXSID70943430
1348935-37-4
8-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-8-azaspiro[4.5]decane-7,9-dione
SB19517
SDCCGSBI-0050194.P002
HMS3742M05
8-azaspiro[4.5]decane-7,9-dione, 8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-
8-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-8-azaspiro(4,5)decane-7,9-dione

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" Rats were treated with vehicle or EEDQ (2 or 6 mg/kg) and 24 hr later dose-response curves were constructed for inhibition of 5-hydroxytrytophan (5-HTP) accumulation (after decarboxylase inhibition with NSD-1015) by the selective 5-HT1A agonists 8-hydroxy-2(di-n-propylamino)tetralin (8-OH-DPAT) (0."( Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
Bohmaker, K; Goldstein, M; Meller, E, 1990
)
0.28
" In contrast, the alpha2-adrenergic receptor antagonist 10(-7) M yohimbine and the alpha1-adrenergic receptor antagonist 10(-9) and 10(-8) M prazosin caused a significant shift in the dose-response curve."( Alpha1A-adrenergic receptors mediate vasoconstriction of the isolated spiral modiolar artery in vitro.
Dang, H; Gruber, DD; Scofield, MA; Shimozono, M; Wangemann, P, 1998
)
0.3
"1 mg kg(-1), displaced the dose-response curve approximately six-fold to the right."( Postjunctional alpha1-adrenoceptors in the vasculature of the pithed mouse are of the alpha1A-subtype.
Ibarra, M; López-Guerrero, JJ; Villalobos-Molina, R, 2005
)
0.33
" Dose-response curves for the alpha1-adrenoceptor agonist phenylephrine were generated in the absence and presence of fentanyl."( Fentanyl attenuates alpha1B-adrenoceptor-mediated pulmonary artery contraction.
Ding, X; McCune, DF; Murray, PA; Perez, DM; Sohn, JT, 2005
)
0.33
" The α(1D)-adrenoceptor antagonist, BMY-7378 (BMY) blocked noradrenaline-induced responses in the order SO > AC7 ≫ AC14; in contrast, the α(1A)-adrenoceptor antagonist RS-100329 (RS), produced a marginal shift to the right of the dose-response curve to noradrenaline, along with a strong decrease of the maximum pressor effect in the order SO > AC7 = AC14."( Effect of inter-renal aortic coarctation-induced hypertension on function and expression of vascular α(1A)- and α(1D)-adrenoceptors.
Gallardo-Ortiz, IA; Ibarra, M; López-Islas, I; López-Sánchez, P; Terrón, JA, 2012
)
0.38
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
piperazines
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (60)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency1.25890.011212.4002100.0000AID1030
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency23.71010.001530.607315,848.9004AID1224819; AID1224820
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency0.02240.035520.977089.1251AID504332
potassium voltage-gated channel subfamily H member 2 isoform dHomo sapiens (human)Potency1.12200.01789.637444.6684AID588834
lamin isoform A-delta10Homo sapiens (human)Potency6.30960.891312.067628.1838AID1487
TDP1 proteinHomo sapiens (human)Potency22.38720.000811.382244.6684AID686978
ThrombopoietinHomo sapiens (human)Potency7.94330.02517.304831.6228AID917; AID918
regulator of G-protein signaling 4Homo sapiens (human)Potency37.68580.531815.435837.6858AID504845
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency21.19230.035520.977089.1251AID504332
flap endonuclease 1Homo sapiens (human)Potency5.32330.133725.412989.1251AID588795
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency29.88160.031610.279239.8107AID884; AID885
muscarinic acetylcholine receptor M1Rattus norvegicus (Norway rat)Potency13.35730.00106.000935.4813AID943; AID944
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency29.88161.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency29.88161.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency29.88161.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency29.88161.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency29.88161.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency29.88161.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency29.88161.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency29.88161.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency29.88161.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency29.88161.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency29.88161.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency29.88161.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency29.88161.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency29.88161.000012.224831.6228AID885
GABA theta subunitRattus norvegicus (Norway rat)Potency29.88161.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency29.88161.000012.224831.6228AID885
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Alpha-1A adrenergic receptorOryctolagus cuniculus (rabbit)Ki0.25120.00000.02040.2512AID36753
5-hydroxytryptamine receptor 1AHomo sapiens (human)Ki0.00170.00010.532610.0000AID3920; AID766558
Alpha-2B adrenergic receptorRattus norvegicus (Norway rat)Ki0.00140.00000.929610.0000AID35460; AID766558
Alpha-2C adrenergic receptorRattus norvegicus (Norway rat)Ki0.00140.00000.970810.0000AID35460; AID766558
Alpha-2A adrenergic receptorRattus norvegicus (Norway rat)Ki0.00140.00000.937510.0000AID35460; AID766558
Alpha-1D adrenergic receptorHomo sapiens (human)Ki0.00250.00000.360910.0000AID35460; AID35468; AID603870
Alpha-1A adrenergic receptorHomo sapiens (human)Ki0.22470.00000.272610.0000AID36747; AID36753; AID603868
Alpha-1B adrenergic receptorHomo sapiens (human)Ki0.46300.00000.471310.0000AID37357; AID37478; AID603869
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)Ki0.00170.00000.965010.0000AID766558
Cytochrome P450 3A4Homo sapiens (human)Ki0.19070.00011.41629.9000AID391751; AID643007
5-hydroxytryptamine receptor 1AHomo sapiens (human)Ki0.00090.00010.532610.0000AID1337884; AID1459193; AID1593198; AID238614; AID239941; AID3823; AID3917; AID391754; AID3934; AID465063; AID510391; AID643008; AID6435; AID723786
5-hydroxytryptamine receptor 2CRattus norvegicus (Norway rat)Ki0.48980.00020.667710.0000AID5084
Alpha-2A adrenergic receptorHomo sapiens (human)Ki0.18200.00010.807410.0000AID36020
Neuronal acetylcholine receptor subunit alpha-4Rattus norvegicus (Norway rat)Ki1.17490.00000.12345.5000AID35499
Cytochrome P450 2C9 Homo sapiens (human)Ki0.00130.00031.684210.0000AID643008
Neuronal acetylcholine receptor subunit beta-2Rattus norvegicus (Norway rat)Ki1.17490.00000.10825.5000AID35499
D(2) dopamine receptorHomo sapiens (human)Ki0.01400.00000.651810.0000AID238380
5-hydroxytryptamine receptor 2ARattus norvegicus (Norway rat)Ki0.48980.00010.601710.0000AID5084
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)Ki0.20920.00010.949010.0000AID36020; AID37510; AID510388; AID643007
Alpha-2B adrenergic receptorHomo sapiens (human)Ki0.18200.00020.725710.0000AID36020
Alpha-1A adrenergic receptorBos taurus (cattle)Ki0.04300.00000.50723.7020AID36458
Alpha-2C adrenergic receptorHomo sapiens (human)Ki0.18200.00030.483410.0000AID36020
DRattus norvegicus (Norway rat)IC50 (µMol)0.09100.00030.50267.7625AID62868
D(3) dopamine receptorRattus norvegicus (Norway rat)IC50 (µMol)0.09100.00030.39075.4000AID62868
D(3) dopamine receptorRattus norvegicus (Norway rat)Ki0.00310.00010.25675.8000AID238354
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)Ki0.02790.00010.739610.0000AID4411; AID4416
Alpha-2B adrenergic receptorRattus norvegicus (Norway rat)Ki0.26960.00000.929610.0000AID35320; AID35499; AID36759
Alpha-2C adrenergic receptorRattus norvegicus (Norway rat)Ki0.26960.00000.970810.0000AID35320; AID35499; AID36759
Alpha-2A adrenergic receptorRattus norvegicus (Norway rat)Ki0.26960.00000.937510.0000AID35320; AID35499; AID36759
Alpha-1D adrenergic receptorRattus norvegicus (Norway rat)Ki0.05580.00000.575110.0000AID35595; AID35601; AID36020; AID391754; AID643008
Alpha-1D adrenergic receptorHomo sapiens (human)Ki0.00160.00000.360910.0000AID1337883; AID1459192; AID1593197; AID238559; AID35307; AID35310; AID35320; AID35459; AID35462; AID35474; AID391753; AID465062; AID510390; AID643007; AID724005
D(1B) dopamine receptorRattus norvegicus (Norway rat)IC50 (µMol)0.09100.00030.35635.4000AID62868
5-hydroxytryptamine receptor 1BRattus norvegicus (Norway rat)Ki10.00000.00031.29679.2440AID4718
D(4) dopamine receptorRattus norvegicus (Norway rat)IC50 (µMol)0.09100.00030.38715.4000AID62868
5-hydroxytryptamine receptor 2BRattus norvegicus (Norway rat)Ki0.48980.00020.590910.0000AID5084
Alpha-1A adrenergic receptorHomo sapiens (human)Ki0.31500.00000.272610.0000AID1337881; AID1459191; AID1593195; AID238557; AID36458; AID36482; AID36484; AID36606; AID36745; AID36759; AID391751; AID464909; AID510388; AID643005; AID724007
Alpha-1B adrenergic receptorHomo sapiens (human)Ki0.50750.00000.471310.0000AID1337882; AID1459190; AID1593196; AID238558; AID37203; AID37206; AID37219; AID37355; AID37358; AID37487; AID391752; AID464910; AID510389; AID643006; AID724006
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)Ki0.35440.00000.965010.0000AID36020; AID36896; AID36898; AID36901; AID391752
D(2) dopamine receptorRattus norvegicus (Norway rat)IC50 (µMol)0.09100.00010.54948.4000AID62868
D(2) dopamine receptorRattus norvegicus (Norway rat)Ki0.04900.00000.437510.0000AID63790
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)Kd0.03310.00020.52667.5858AID35152
Alpha-2B adrenergic receptorRattus norvegicus (Norway rat)Kd5.05740.00020.62779.3325AID35364; AID36913
Alpha-mannosidase 2C1Rattus norvegicus (Norway rat)Kd10.00003.71533.71533.7153AID35364
Alpha-2C adrenergic receptorRattus norvegicus (Norway rat)Kd5.05740.00020.62779.3325AID35364; AID36913
Alpha-2A adrenergic receptorRattus norvegicus (Norway rat)Kd5.05740.00020.62779.3325AID35364; AID36913
Adenosine receptor A2bRattus norvegicus (Norway rat)Kd0.38020.05300.17620.3802AID36625
Adenosine receptor A2aRattus norvegicus (Norway rat)Kd0.38020.00020.04910.3802AID36625
Alpha-1A adrenergic receptorHomo sapiens (human)Kd0.38020.00000.20481.2882AID36625
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)Kd0.11480.00020.51397.5858AID36913
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Alpha-1A adrenergic receptorOryctolagus cuniculus (rabbit)Kb1.45001.45001.45001.4500AID692055
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (207)

Processvia Protein(s)Taxonomy
behavioral fear response5-hydroxytryptamine receptor 1AHomo sapiens (human)
G protein-coupled receptor signaling pathway5-hydroxytryptamine receptor 1AHomo sapiens (human)
adenylate cyclase-inhibiting serotonin receptor signaling pathway5-hydroxytryptamine receptor 1AHomo sapiens (human)
serotonin receptor signaling pathway5-hydroxytryptamine receptor 1AHomo sapiens (human)
gamma-aminobutyric acid signaling pathway5-hydroxytryptamine receptor 1AHomo sapiens (human)
positive regulation of cell population proliferation5-hydroxytryptamine receptor 1AHomo sapiens (human)
regulation of serotonin secretion5-hydroxytryptamine receptor 1AHomo sapiens (human)
regulation of vasoconstriction5-hydroxytryptamine receptor 1AHomo sapiens (human)
exploration behavior5-hydroxytryptamine receptor 1AHomo sapiens (human)
regulation of dopamine metabolic process5-hydroxytryptamine receptor 1AHomo sapiens (human)
serotonin metabolic process5-hydroxytryptamine receptor 1AHomo sapiens (human)
regulation of hormone secretion5-hydroxytryptamine receptor 1AHomo sapiens (human)
regulation of behavior5-hydroxytryptamine receptor 1AHomo sapiens (human)
chemical synaptic transmission5-hydroxytryptamine receptor 1AHomo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger5-hydroxytryptamine receptor 1AHomo sapiens (human)
G protein-coupled receptor signaling pathwayAlpha-1D adrenergic receptorHomo sapiens (human)
adenylate cyclase-modulating G protein-coupled receptor signaling pathwayAlpha-1D adrenergic receptorHomo sapiens (human)
positive regulation of cell population proliferationAlpha-1D adrenergic receptorHomo sapiens (human)
neuron-glial cell signalingAlpha-1D adrenergic receptorHomo sapiens (human)
cell-cell signalingAlpha-1D adrenergic receptorHomo sapiens (human)
adenylate cyclase-activating adrenergic receptor signaling pathwayAlpha-1D adrenergic receptorHomo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayAlpha-1D adrenergic receptorHomo sapiens (human)
positive regulation of cytosolic calcium ion concentrationAlpha-1D adrenergic receptorHomo sapiens (human)
positive regulation of vasoconstrictionAlpha-1D adrenergic receptorHomo sapiens (human)
positive regulation of MAPK cascadeAlpha-1D adrenergic receptorHomo sapiens (human)
MAPK cascadeAlpha-1A adrenergic receptorHomo sapiens (human)
negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressureAlpha-1A adrenergic receptorHomo sapiens (human)
norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressureAlpha-1A adrenergic receptorHomo sapiens (human)
positive regulation of heart rate by epinephrine-norepinephrineAlpha-1A adrenergic receptorHomo sapiens (human)
positive regulation of the force of heart contraction by epinephrine-norepinephrineAlpha-1A adrenergic receptorHomo sapiens (human)
apoptotic processAlpha-1A adrenergic receptorHomo sapiens (human)
smooth muscle contractionAlpha-1A adrenergic receptorHomo sapiens (human)
signal transductionAlpha-1A adrenergic receptorHomo sapiens (human)
G protein-coupled receptor signaling pathwayAlpha-1A adrenergic receptorHomo sapiens (human)
activation of phospholipase C activityAlpha-1A adrenergic receptorHomo sapiens (human)
positive regulation of cytosolic calcium ion concentrationAlpha-1A adrenergic receptorHomo sapiens (human)
adult heart developmentAlpha-1A adrenergic receptorHomo sapiens (human)
negative regulation of cell population proliferationAlpha-1A adrenergic receptorHomo sapiens (human)
response to xenobiotic stimulusAlpha-1A adrenergic receptorHomo sapiens (human)
response to hormoneAlpha-1A adrenergic receptorHomo sapiens (human)
negative regulation of autophagyAlpha-1A adrenergic receptorHomo sapiens (human)
positive regulation of cardiac muscle hypertrophyAlpha-1A adrenergic receptorHomo sapiens (human)
positive regulation of synaptic transmission, GABAergicAlpha-1A adrenergic receptorHomo sapiens (human)
intracellular signal transductionAlpha-1A adrenergic receptorHomo sapiens (human)
positive regulation of MAPK cascadeAlpha-1A adrenergic receptorHomo sapiens (human)
positive regulation of action potentialAlpha-1A adrenergic receptorHomo sapiens (human)
positive regulation of vasoconstrictionAlpha-1A adrenergic receptorHomo sapiens (human)
positive regulation of smooth muscle contractionAlpha-1A adrenergic receptorHomo sapiens (human)
calcium ion transport into cytosolAlpha-1A adrenergic receptorHomo sapiens (human)
positive regulation of cardiac muscle contractionAlpha-1A adrenergic receptorHomo sapiens (human)
cell growth involved in cardiac muscle cell developmentAlpha-1A adrenergic receptorHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeAlpha-1A adrenergic receptorHomo sapiens (human)
positive regulation of protein kinase C signalingAlpha-1A adrenergic receptorHomo sapiens (human)
pilomotor reflexAlpha-1A adrenergic receptorHomo sapiens (human)
neuron-glial cell signalingAlpha-1A adrenergic receptorHomo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayAlpha-1A adrenergic receptorHomo sapiens (human)
adenylate cyclase-activating adrenergic receptor signaling pathwayAlpha-1A adrenergic receptorHomo sapiens (human)
cell-cell signalingAlpha-1A adrenergic receptorHomo sapiens (human)
G protein-coupled receptor signaling pathwayAlpha-1B adrenergic receptorHomo sapiens (human)
adenylate cyclase-modulating G protein-coupled receptor signaling pathwayAlpha-1B adrenergic receptorHomo sapiens (human)
regulation of vasoconstrictionAlpha-1B adrenergic receptorHomo sapiens (human)
intracellular signal transductionAlpha-1B adrenergic receptorHomo sapiens (human)
positive regulation of MAPK cascadeAlpha-1B adrenergic receptorHomo sapiens (human)
regulation of cardiac muscle contractionAlpha-1B adrenergic receptorHomo sapiens (human)
neuron-glial cell signalingAlpha-1B adrenergic receptorHomo sapiens (human)
adenylate cyclase-activating adrenergic receptor signaling pathwayAlpha-1B adrenergic receptorHomo sapiens (human)
cell-cell signalingAlpha-1B adrenergic receptorHomo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayAlpha-1B adrenergic receptorHomo sapiens (human)
positive regulation of cytosolic calcium ion concentrationAlpha-1B adrenergic receptorHomo sapiens (human)
lipid hydroxylationCytochrome P450 3A4Homo sapiens (human)
lipid metabolic processCytochrome P450 3A4Homo sapiens (human)
steroid catabolic processCytochrome P450 3A4Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 3A4Homo sapiens (human)
steroid metabolic processCytochrome P450 3A4Homo sapiens (human)
cholesterol metabolic processCytochrome P450 3A4Homo sapiens (human)
androgen metabolic processCytochrome P450 3A4Homo sapiens (human)
estrogen metabolic processCytochrome P450 3A4Homo sapiens (human)
alkaloid catabolic processCytochrome P450 3A4Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 3A4Homo sapiens (human)
calcitriol biosynthetic process from calciolCytochrome P450 3A4Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 3A4Homo sapiens (human)
vitamin D metabolic processCytochrome P450 3A4Homo sapiens (human)
vitamin D catabolic processCytochrome P450 3A4Homo sapiens (human)
retinol metabolic processCytochrome P450 3A4Homo sapiens (human)
retinoic acid metabolic processCytochrome P450 3A4Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 3A4Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 3A4Homo sapiens (human)
oxidative demethylationCytochrome P450 3A4Homo sapiens (human)
behavioral fear response5-hydroxytryptamine receptor 1AHomo sapiens (human)
G protein-coupled receptor signaling pathway5-hydroxytryptamine receptor 1AHomo sapiens (human)
adenylate cyclase-inhibiting serotonin receptor signaling pathway5-hydroxytryptamine receptor 1AHomo sapiens (human)
serotonin receptor signaling pathway5-hydroxytryptamine receptor 1AHomo sapiens (human)
gamma-aminobutyric acid signaling pathway5-hydroxytryptamine receptor 1AHomo sapiens (human)
positive regulation of cell population proliferation5-hydroxytryptamine receptor 1AHomo sapiens (human)
regulation of serotonin secretion5-hydroxytryptamine receptor 1AHomo sapiens (human)
regulation of vasoconstriction5-hydroxytryptamine receptor 1AHomo sapiens (human)
exploration behavior5-hydroxytryptamine receptor 1AHomo sapiens (human)
regulation of dopamine metabolic process5-hydroxytryptamine receptor 1AHomo sapiens (human)
serotonin metabolic process5-hydroxytryptamine receptor 1AHomo sapiens (human)
regulation of hormone secretion5-hydroxytryptamine receptor 1AHomo sapiens (human)
regulation of behavior5-hydroxytryptamine receptor 1AHomo sapiens (human)
chemical synaptic transmission5-hydroxytryptamine receptor 1AHomo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger5-hydroxytryptamine receptor 1AHomo sapiens (human)
positive regulation of cytokine productionAlpha-2A adrenergic receptorHomo sapiens (human)
DNA replicationAlpha-2A adrenergic receptorHomo sapiens (human)
G protein-coupled receptor signaling pathwayAlpha-2A adrenergic receptorHomo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayAlpha-2A adrenergic receptorHomo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathwayAlpha-2A adrenergic receptorHomo sapiens (human)
Ras protein signal transductionAlpha-2A adrenergic receptorHomo sapiens (human)
Rho protein signal transductionAlpha-2A adrenergic receptorHomo sapiens (human)
female pregnancyAlpha-2A adrenergic receptorHomo sapiens (human)
positive regulation of cell population proliferationAlpha-2A adrenergic receptorHomo sapiens (human)
negative regulation of norepinephrine secretionAlpha-2A adrenergic receptorHomo sapiens (human)
regulation of vasoconstrictionAlpha-2A adrenergic receptorHomo sapiens (human)
actin cytoskeleton organizationAlpha-2A adrenergic receptorHomo sapiens (human)
platelet activationAlpha-2A adrenergic receptorHomo sapiens (human)
positive regulation of cell migrationAlpha-2A adrenergic receptorHomo sapiens (human)
activation of protein kinase activityAlpha-2A adrenergic receptorHomo sapiens (human)
activation of protein kinase B activityAlpha-2A adrenergic receptorHomo sapiens (human)
negative regulation of epinephrine secretionAlpha-2A adrenergic receptorHomo sapiens (human)
cellular response to hormone stimulusAlpha-2A adrenergic receptorHomo sapiens (human)
receptor transactivationAlpha-2A adrenergic receptorHomo sapiens (human)
vasodilationAlpha-2A adrenergic receptorHomo sapiens (human)
glucose homeostasisAlpha-2A adrenergic receptorHomo sapiens (human)
fear responseAlpha-2A adrenergic receptorHomo sapiens (human)
positive regulation of potassium ion transportAlpha-2A adrenergic receptorHomo sapiens (human)
positive regulation of MAP kinase activityAlpha-2A adrenergic receptorHomo sapiens (human)
positive regulation of MAPK cascadeAlpha-2A adrenergic receptorHomo sapiens (human)
positive regulation of epidermal growth factor receptor signaling pathwayAlpha-2A adrenergic receptorHomo sapiens (human)
negative regulation of calcium ion-dependent exocytosisAlpha-2A adrenergic receptorHomo sapiens (human)
negative regulation of insulin secretionAlpha-2A adrenergic receptorHomo sapiens (human)
intestinal absorptionAlpha-2A adrenergic receptorHomo sapiens (human)
thermoceptionAlpha-2A adrenergic receptorHomo sapiens (human)
negative regulation of lipid catabolic processAlpha-2A adrenergic receptorHomo sapiens (human)
positive regulation of membrane protein ectodomain proteolysisAlpha-2A adrenergic receptorHomo sapiens (human)
negative regulation of calcium ion transportAlpha-2A adrenergic receptorHomo sapiens (human)
negative regulation of insulin secretion involved in cellular response to glucose stimulusAlpha-2A adrenergic receptorHomo sapiens (human)
negative regulation of uterine smooth muscle contractionAlpha-2A adrenergic receptorHomo sapiens (human)
adrenergic receptor signaling pathwayAlpha-2A adrenergic receptorHomo sapiens (human)
adenylate cyclase-activating adrenergic receptor signaling pathwayAlpha-2A adrenergic receptorHomo sapiens (human)
adenylate cyclase-inhibiting adrenergic receptor signaling pathwayAlpha-2A adrenergic receptorHomo sapiens (human)
phospholipase C-activating adrenergic receptor signaling pathwayAlpha-2A adrenergic receptorHomo sapiens (human)
positive regulation of wound healingAlpha-2A adrenergic receptorHomo sapiens (human)
presynaptic modulation of chemical synaptic transmissionAlpha-2A adrenergic receptorHomo sapiens (human)
negative regulation of calcium ion transmembrane transporter activityAlpha-2A adrenergic receptorHomo sapiens (human)
xenobiotic metabolic processCytochrome P450 2C9 Homo sapiens (human)
steroid metabolic processCytochrome P450 2C9 Homo sapiens (human)
cholesterol metabolic processCytochrome P450 2C9 Homo sapiens (human)
estrogen metabolic processCytochrome P450 2C9 Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 2C9 Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2C9 Homo sapiens (human)
urea metabolic processCytochrome P450 2C9 Homo sapiens (human)
monocarboxylic acid metabolic processCytochrome P450 2C9 Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 2C9 Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 2C9 Homo sapiens (human)
amide metabolic processCytochrome P450 2C9 Homo sapiens (human)
icosanoid biosynthetic processCytochrome P450 2C9 Homo sapiens (human)
oxidative demethylationCytochrome P450 2C9 Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 2C9 Homo sapiens (human)
phospholipase C-activating dopamine receptor signaling pathwayD(2) dopamine receptorHomo sapiens (human)
temperature homeostasisD(2) dopamine receptorHomo sapiens (human)
response to hypoxiaD(2) dopamine receptorHomo sapiens (human)
negative regulation of protein phosphorylationD(2) dopamine receptorHomo sapiens (human)
response to amphetamineD(2) dopamine receptorHomo sapiens (human)
nervous system process involved in regulation of systemic arterial blood pressureD(2) dopamine receptorHomo sapiens (human)
regulation of heart rateD(2) dopamine receptorHomo sapiens (human)
regulation of sodium ion transportD(2) dopamine receptorHomo sapiens (human)
G protein-coupled receptor internalizationD(2) dopamine receptorHomo sapiens (human)
positive regulation of neuroblast proliferationD(2) dopamine receptorHomo sapiens (human)
positive regulation of receptor internalizationD(2) dopamine receptorHomo sapiens (human)
autophagyD(2) dopamine receptorHomo sapiens (human)
adenylate cyclase-inhibiting dopamine receptor signaling pathwayD(2) dopamine receptorHomo sapiens (human)
neuron-neuron synaptic transmissionD(2) dopamine receptorHomo sapiens (human)
neuroblast proliferationD(2) dopamine receptorHomo sapiens (human)
axonogenesisD(2) dopamine receptorHomo sapiens (human)
synapse assemblyD(2) dopamine receptorHomo sapiens (human)
sensory perception of smellD(2) dopamine receptorHomo sapiens (human)
long-term memoryD(2) dopamine receptorHomo sapiens (human)
grooming behaviorD(2) dopamine receptorHomo sapiens (human)
locomotory behaviorD(2) dopamine receptorHomo sapiens (human)
adult walking behaviorD(2) dopamine receptorHomo sapiens (human)
protein localizationD(2) dopamine receptorHomo sapiens (human)
negative regulation of cell population proliferationD(2) dopamine receptorHomo sapiens (human)
associative learningD(2) dopamine receptorHomo sapiens (human)
visual learningD(2) dopamine receptorHomo sapiens (human)
response to xenobiotic stimulusD(2) dopamine receptorHomo sapiens (human)
response to light stimulusD(2) dopamine receptorHomo sapiens (human)
response to toxic substanceD(2) dopamine receptorHomo sapiens (human)
response to iron ionD(2) dopamine receptorHomo sapiens (human)
response to inactivityD(2) dopamine receptorHomo sapiens (human)
Wnt signaling pathwayD(2) dopamine receptorHomo sapiens (human)
striatum developmentD(2) dopamine receptorHomo sapiens (human)
orbitofrontal cortex developmentD(2) dopamine receptorHomo sapiens (human)
cerebral cortex GABAergic interneuron migrationD(2) dopamine receptorHomo sapiens (human)
adenohypophysis developmentD(2) dopamine receptorHomo sapiens (human)
negative regulation of cell migrationD(2) dopamine receptorHomo sapiens (human)
peristalsisD(2) dopamine receptorHomo sapiens (human)
auditory behaviorD(2) dopamine receptorHomo sapiens (human)
regulation of synaptic transmission, GABAergicD(2) dopamine receptorHomo sapiens (human)
positive regulation of cytokinesisD(2) dopamine receptorHomo sapiens (human)
circadian regulation of gene expressionD(2) dopamine receptorHomo sapiens (human)
negative regulation of dopamine secretionD(2) dopamine receptorHomo sapiens (human)
response to histamineD(2) dopamine receptorHomo sapiens (human)
response to nicotineD(2) dopamine receptorHomo sapiens (human)
positive regulation of urine volumeD(2) dopamine receptorHomo sapiens (human)
positive regulation of renal sodium excretionD(2) dopamine receptorHomo sapiens (human)
positive regulation of multicellular organism growthD(2) dopamine receptorHomo sapiens (human)
response to cocaineD(2) dopamine receptorHomo sapiens (human)
negative regulation of circadian sleep/wake cycle, sleepD(2) dopamine receptorHomo sapiens (human)
dopamine metabolic processD(2) dopamine receptorHomo sapiens (human)
drinking behaviorD(2) dopamine receptorHomo sapiens (human)
regulation of potassium ion transportD(2) dopamine receptorHomo sapiens (human)
response to morphineD(2) dopamine receptorHomo sapiens (human)
pigmentationD(2) dopamine receptorHomo sapiens (human)
phosphatidylinositol 3-kinase/protein kinase B signal transductionD(2) dopamine receptorHomo sapiens (human)
positive regulation of G protein-coupled receptor signaling pathwayD(2) dopamine receptorHomo sapiens (human)
negative regulation of blood pressureD(2) dopamine receptorHomo sapiens (human)
negative regulation of innate immune responseD(2) dopamine receptorHomo sapiens (human)
positive regulation of transcription by RNA polymerase IID(2) dopamine receptorHomo sapiens (human)
negative regulation of insulin secretionD(2) dopamine receptorHomo sapiens (human)
acid secretionD(2) dopamine receptorHomo sapiens (human)
behavioral response to cocaineD(2) dopamine receptorHomo sapiens (human)
behavioral response to ethanolD(2) dopamine receptorHomo sapiens (human)
regulation of long-term neuronal synaptic plasticityD(2) dopamine receptorHomo sapiens (human)
response to axon injuryD(2) dopamine receptorHomo sapiens (human)
branching morphogenesis of a nerveD(2) dopamine receptorHomo sapiens (human)
arachidonic acid secretionD(2) dopamine receptorHomo sapiens (human)
epithelial cell proliferationD(2) dopamine receptorHomo sapiens (human)
negative regulation of epithelial cell proliferationD(2) dopamine receptorHomo sapiens (human)
negative regulation of protein secretionD(2) dopamine receptorHomo sapiens (human)
release of sequestered calcium ion into cytosolD(2) dopamine receptorHomo sapiens (human)
dopamine uptake involved in synaptic transmissionD(2) dopamine receptorHomo sapiens (human)
regulation of dopamine uptake involved in synaptic transmissionD(2) dopamine receptorHomo sapiens (human)
positive regulation of dopamine uptake involved in synaptic transmissionD(2) dopamine receptorHomo sapiens (human)
regulation of synapse structural plasticityD(2) dopamine receptorHomo sapiens (human)
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionD(2) dopamine receptorHomo sapiens (human)
negative regulation of synaptic transmission, glutamatergicD(2) dopamine receptorHomo sapiens (human)
excitatory postsynaptic potentialD(2) dopamine receptorHomo sapiens (human)
positive regulation of growth hormone secretionD(2) dopamine receptorHomo sapiens (human)
prepulse inhibitionD(2) dopamine receptorHomo sapiens (human)
negative regulation of dopamine receptor signaling pathwayD(2) dopamine receptorHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeD(2) dopamine receptorHomo sapiens (human)
regulation of locomotion involved in locomotory behaviorD(2) dopamine receptorHomo sapiens (human)
postsynaptic modulation of chemical synaptic transmissionD(2) dopamine receptorHomo sapiens (human)
presynaptic modulation of chemical synaptic transmissionD(2) dopamine receptorHomo sapiens (human)
negative regulation of cellular response to hypoxiaD(2) dopamine receptorHomo sapiens (human)
positive regulation of glial cell-derived neurotrophic factor productionD(2) dopamine receptorHomo sapiens (human)
positive regulation of long-term synaptic potentiationD(2) dopamine receptorHomo sapiens (human)
hyaloid vascular plexus regressionD(2) dopamine receptorHomo sapiens (human)
negative regulation of neuron migrationD(2) dopamine receptorHomo sapiens (human)
negative regulation of cytosolic calcium ion concentrationD(2) dopamine receptorHomo sapiens (human)
regulation of dopamine secretionD(2) dopamine receptorHomo sapiens (human)
negative regulation of adenylate cyclase activityD(2) dopamine receptorHomo sapiens (human)
phospholipase C-activating dopamine receptor signaling pathwayD(2) dopamine receptorHomo sapiens (human)
negative regulation of voltage-gated calcium channel activityD(2) dopamine receptorHomo sapiens (human)
positive regulation of MAPK cascadeD(2) dopamine receptorHomo sapiens (human)
adenylate cyclase-activating adrenergic receptor signaling pathwayD(2) dopamine receptorHomo sapiens (human)
MAPK cascadeAlpha-2B adrenergic receptorHomo sapiens (human)
angiogenesisAlpha-2B adrenergic receptorHomo sapiens (human)
regulation of vascular associated smooth muscle contractionAlpha-2B adrenergic receptorHomo sapiens (human)
G protein-coupled receptor signaling pathwayAlpha-2B adrenergic receptorHomo sapiens (human)
cell-cell signalingAlpha-2B adrenergic receptorHomo sapiens (human)
female pregnancyAlpha-2B adrenergic receptorHomo sapiens (human)
negative regulation of norepinephrine secretionAlpha-2B adrenergic receptorHomo sapiens (human)
platelet activationAlpha-2B adrenergic receptorHomo sapiens (human)
activation of protein kinase B activityAlpha-2B adrenergic receptorHomo sapiens (human)
negative regulation of epinephrine secretionAlpha-2B adrenergic receptorHomo sapiens (human)
receptor transactivationAlpha-2B adrenergic receptorHomo sapiens (human)
positive regulation of MAPK cascadeAlpha-2B adrenergic receptorHomo sapiens (human)
positive regulation of neuron differentiationAlpha-2B adrenergic receptorHomo sapiens (human)
positive regulation of blood pressureAlpha-2B adrenergic receptorHomo sapiens (human)
positive regulation of uterine smooth muscle contractionAlpha-2B adrenergic receptorHomo sapiens (human)
adrenergic receptor signaling pathwayAlpha-2B adrenergic receptorHomo sapiens (human)
adenylate cyclase-activating adrenergic receptor signaling pathwayAlpha-2B adrenergic receptorHomo sapiens (human)
regulation of vasoconstrictionAlpha-1A adrenergic receptorBos taurus (cattle)
positive regulation of MAPK cascadeAlpha-1A adrenergic receptorBos taurus (cattle)
regulation of cardiac muscle contractionAlpha-1A adrenergic receptorBos taurus (cattle)
regulation of smooth muscle contractionAlpha-2C adrenergic receptorHomo sapiens (human)
G protein-coupled receptor signaling pathwayAlpha-2C adrenergic receptorHomo sapiens (human)
cell-cell signalingAlpha-2C adrenergic receptorHomo sapiens (human)
negative regulation of norepinephrine secretionAlpha-2C adrenergic receptorHomo sapiens (human)
regulation of vasoconstrictionAlpha-2C adrenergic receptorHomo sapiens (human)
platelet activationAlpha-2C adrenergic receptorHomo sapiens (human)
activation of protein kinase B activityAlpha-2C adrenergic receptorHomo sapiens (human)
negative regulation of epinephrine secretionAlpha-2C adrenergic receptorHomo sapiens (human)
receptor transactivationAlpha-2C adrenergic receptorHomo sapiens (human)
positive regulation of MAPK cascadeAlpha-2C adrenergic receptorHomo sapiens (human)
positive regulation of neuron differentiationAlpha-2C adrenergic receptorHomo sapiens (human)
adrenergic receptor signaling pathwayAlpha-2C adrenergic receptorHomo sapiens (human)
adenylate cyclase-activating adrenergic receptor signaling pathwayAlpha-2C adrenergic receptorHomo sapiens (human)
negative regulation of insulin secretionAlpha-2C adrenergic receptorHomo sapiens (human)
G protein-coupled receptor signaling pathwayAlpha-1D adrenergic receptorHomo sapiens (human)
adenylate cyclase-modulating G protein-coupled receptor signaling pathwayAlpha-1D adrenergic receptorHomo sapiens (human)
positive regulation of cell population proliferationAlpha-1D adrenergic receptorHomo sapiens (human)
neuron-glial cell signalingAlpha-1D adrenergic receptorHomo sapiens (human)
cell-cell signalingAlpha-1D adrenergic receptorHomo sapiens (human)
adenylate cyclase-activating adrenergic receptor signaling pathwayAlpha-1D adrenergic receptorHomo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayAlpha-1D adrenergic receptorHomo sapiens (human)
positive regulation of cytosolic calcium ion concentrationAlpha-1D adrenergic receptorHomo sapiens (human)
positive regulation of vasoconstrictionAlpha-1D adrenergic receptorHomo sapiens (human)
positive regulation of MAPK cascadeAlpha-1D adrenergic receptorHomo sapiens (human)
MAPK cascadeAlpha-1A adrenergic receptorHomo sapiens (human)
negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressureAlpha-1A adrenergic receptorHomo sapiens (human)
norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressureAlpha-1A adrenergic receptorHomo sapiens (human)
positive regulation of heart rate by epinephrine-norepinephrineAlpha-1A adrenergic receptorHomo sapiens (human)
positive regulation of the force of heart contraction by epinephrine-norepinephrineAlpha-1A adrenergic receptorHomo sapiens (human)
apoptotic processAlpha-1A adrenergic receptorHomo sapiens (human)
smooth muscle contractionAlpha-1A adrenergic receptorHomo sapiens (human)
signal transductionAlpha-1A adrenergic receptorHomo sapiens (human)
G protein-coupled receptor signaling pathwayAlpha-1A adrenergic receptorHomo sapiens (human)
activation of phospholipase C activityAlpha-1A adrenergic receptorHomo sapiens (human)
positive regulation of cytosolic calcium ion concentrationAlpha-1A adrenergic receptorHomo sapiens (human)
adult heart developmentAlpha-1A adrenergic receptorHomo sapiens (human)
negative regulation of cell population proliferationAlpha-1A adrenergic receptorHomo sapiens (human)
response to xenobiotic stimulusAlpha-1A adrenergic receptorHomo sapiens (human)
response to hormoneAlpha-1A adrenergic receptorHomo sapiens (human)
negative regulation of autophagyAlpha-1A adrenergic receptorHomo sapiens (human)
positive regulation of cardiac muscle hypertrophyAlpha-1A adrenergic receptorHomo sapiens (human)
positive regulation of synaptic transmission, GABAergicAlpha-1A adrenergic receptorHomo sapiens (human)
intracellular signal transductionAlpha-1A adrenergic receptorHomo sapiens (human)
positive regulation of MAPK cascadeAlpha-1A adrenergic receptorHomo sapiens (human)
positive regulation of action potentialAlpha-1A adrenergic receptorHomo sapiens (human)
positive regulation of vasoconstrictionAlpha-1A adrenergic receptorHomo sapiens (human)
positive regulation of smooth muscle contractionAlpha-1A adrenergic receptorHomo sapiens (human)
calcium ion transport into cytosolAlpha-1A adrenergic receptorHomo sapiens (human)
positive regulation of cardiac muscle contractionAlpha-1A adrenergic receptorHomo sapiens (human)
cell growth involved in cardiac muscle cell developmentAlpha-1A adrenergic receptorHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeAlpha-1A adrenergic receptorHomo sapiens (human)
positive regulation of protein kinase C signalingAlpha-1A adrenergic receptorHomo sapiens (human)
pilomotor reflexAlpha-1A adrenergic receptorHomo sapiens (human)
neuron-glial cell signalingAlpha-1A adrenergic receptorHomo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayAlpha-1A adrenergic receptorHomo sapiens (human)
adenylate cyclase-activating adrenergic receptor signaling pathwayAlpha-1A adrenergic receptorHomo sapiens (human)
cell-cell signalingAlpha-1A adrenergic receptorHomo sapiens (human)
G protein-coupled receptor signaling pathwayAlpha-1B adrenergic receptorHomo sapiens (human)
adenylate cyclase-modulating G protein-coupled receptor signaling pathwayAlpha-1B adrenergic receptorHomo sapiens (human)
regulation of vasoconstrictionAlpha-1B adrenergic receptorHomo sapiens (human)
intracellular signal transductionAlpha-1B adrenergic receptorHomo sapiens (human)
positive regulation of MAPK cascadeAlpha-1B adrenergic receptorHomo sapiens (human)
regulation of cardiac muscle contractionAlpha-1B adrenergic receptorHomo sapiens (human)
neuron-glial cell signalingAlpha-1B adrenergic receptorHomo sapiens (human)
adenylate cyclase-activating adrenergic receptor signaling pathwayAlpha-1B adrenergic receptorHomo sapiens (human)
cell-cell signalingAlpha-1B adrenergic receptorHomo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayAlpha-1B adrenergic receptorHomo sapiens (human)
positive regulation of cytosolic calcium ion concentrationAlpha-1B adrenergic receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (55)

Processvia Protein(s)Taxonomy
G protein-coupled serotonin receptor activity5-hydroxytryptamine receptor 1AHomo sapiens (human)
protein binding5-hydroxytryptamine receptor 1AHomo sapiens (human)
receptor-receptor interaction5-hydroxytryptamine receptor 1AHomo sapiens (human)
neurotransmitter receptor activity5-hydroxytryptamine receptor 1AHomo sapiens (human)
serotonin binding5-hydroxytryptamine receptor 1AHomo sapiens (human)
protein bindingAlpha-1D adrenergic receptorHomo sapiens (human)
identical protein bindingAlpha-1D adrenergic receptorHomo sapiens (human)
alpha1-adrenergic receptor activityAlpha-1D adrenergic receptorHomo sapiens (human)
alpha1-adrenergic receptor activityAlpha-1A adrenergic receptorHomo sapiens (human)
protein bindingAlpha-1A adrenergic receptorHomo sapiens (human)
protein heterodimerization activityAlpha-1A adrenergic receptorHomo sapiens (human)
protein bindingAlpha-1B adrenergic receptorHomo sapiens (human)
protein heterodimerization activityAlpha-1B adrenergic receptorHomo sapiens (human)
alpha1-adrenergic receptor activityAlpha-1B adrenergic receptorHomo sapiens (human)
monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
steroid bindingCytochrome P450 3A4Homo sapiens (human)
iron ion bindingCytochrome P450 3A4Homo sapiens (human)
protein bindingCytochrome P450 3A4Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
retinoic acid 4-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
oxidoreductase activityCytochrome P450 3A4Homo sapiens (human)
oxygen bindingCytochrome P450 3A4Homo sapiens (human)
enzyme bindingCytochrome P450 3A4Homo sapiens (human)
heme bindingCytochrome P450 3A4Homo sapiens (human)
vitamin D3 25-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
caffeine oxidase activityCytochrome P450 3A4Homo sapiens (human)
quinine 3-monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
testosterone 6-beta-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 8,9 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 11,12 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 14,15 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
aromatase activityCytochrome P450 3A4Homo sapiens (human)
vitamin D 24-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
1,8-cineole 2-exo-monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
G protein-coupled serotonin receptor activity5-hydroxytryptamine receptor 1AHomo sapiens (human)
protein binding5-hydroxytryptamine receptor 1AHomo sapiens (human)
receptor-receptor interaction5-hydroxytryptamine receptor 1AHomo sapiens (human)
neurotransmitter receptor activity5-hydroxytryptamine receptor 1AHomo sapiens (human)
serotonin binding5-hydroxytryptamine receptor 1AHomo sapiens (human)
alpha2-adrenergic receptor activityAlpha-2A adrenergic receptorHomo sapiens (human)
protein bindingAlpha-2A adrenergic receptorHomo sapiens (human)
protein kinase bindingAlpha-2A adrenergic receptorHomo sapiens (human)
alpha-1B adrenergic receptor bindingAlpha-2A adrenergic receptorHomo sapiens (human)
alpha-2C adrenergic receptor bindingAlpha-2A adrenergic receptorHomo sapiens (human)
thioesterase bindingAlpha-2A adrenergic receptorHomo sapiens (human)
heterotrimeric G-protein bindingAlpha-2A adrenergic receptorHomo sapiens (human)
protein homodimerization activityAlpha-2A adrenergic receptorHomo sapiens (human)
protein heterodimerization activityAlpha-2A adrenergic receptorHomo sapiens (human)
epinephrine bindingAlpha-2A adrenergic receptorHomo sapiens (human)
norepinephrine bindingAlpha-2A adrenergic receptorHomo sapiens (human)
guanyl-nucleotide exchange factor activityAlpha-2A adrenergic receptorHomo sapiens (human)
monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
iron ion bindingCytochrome P450 2C9 Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2C9 Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 2C9 Homo sapiens (human)
arachidonic acid 14,15-epoxygenase activityCytochrome P450 2C9 Homo sapiens (human)
arachidonic acid 11,12-epoxygenase activityCytochrome P450 2C9 Homo sapiens (human)
oxidoreductase activityCytochrome P450 2C9 Homo sapiens (human)
(S)-limonene 6-monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
(S)-limonene 7-monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
caffeine oxidase activityCytochrome P450 2C9 Homo sapiens (human)
(R)-limonene 6-monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
aromatase activityCytochrome P450 2C9 Homo sapiens (human)
heme bindingCytochrome P450 2C9 Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2C9 Homo sapiens (human)
dopamine neurotransmitter receptor activity, coupled via Gi/GoD(2) dopamine receptorHomo sapiens (human)
G-protein alpha-subunit bindingD(2) dopamine receptorHomo sapiens (human)
protein bindingD(2) dopamine receptorHomo sapiens (human)
heterotrimeric G-protein bindingD(2) dopamine receptorHomo sapiens (human)
dopamine bindingD(2) dopamine receptorHomo sapiens (human)
ionotropic glutamate receptor bindingD(2) dopamine receptorHomo sapiens (human)
identical protein bindingD(2) dopamine receptorHomo sapiens (human)
heterocyclic compound bindingD(2) dopamine receptorHomo sapiens (human)
G protein-coupled receptor activityD(2) dopamine receptorHomo sapiens (human)
alpha2-adrenergic receptor activityAlpha-2B adrenergic receptorHomo sapiens (human)
protein bindingAlpha-2B adrenergic receptorHomo sapiens (human)
epinephrine bindingAlpha-2B adrenergic receptorHomo sapiens (human)
protein heterodimerization activityAlpha-1A adrenergic receptorBos taurus (cattle)
alpha2-adrenergic receptor activityAlpha-2C adrenergic receptorHomo sapiens (human)
protein bindingAlpha-2C adrenergic receptorHomo sapiens (human)
alpha-2A adrenergic receptor bindingAlpha-2C adrenergic receptorHomo sapiens (human)
protein homodimerization activityAlpha-2C adrenergic receptorHomo sapiens (human)
protein heterodimerization activityAlpha-2C adrenergic receptorHomo sapiens (human)
epinephrine bindingAlpha-2C adrenergic receptorHomo sapiens (human)
guanyl-nucleotide exchange factor activityAlpha-2C adrenergic receptorHomo sapiens (human)
protein bindingAlpha-1D adrenergic receptorHomo sapiens (human)
identical protein bindingAlpha-1D adrenergic receptorHomo sapiens (human)
alpha1-adrenergic receptor activityAlpha-1D adrenergic receptorHomo sapiens (human)
G protein-coupled adenosine receptor activityAdenosine receptor A2aRattus norvegicus (Norway rat)
alpha1-adrenergic receptor activityAlpha-1A adrenergic receptorHomo sapiens (human)
protein bindingAlpha-1A adrenergic receptorHomo sapiens (human)
protein heterodimerization activityAlpha-1A adrenergic receptorHomo sapiens (human)
protein bindingAlpha-1B adrenergic receptorHomo sapiens (human)
protein heterodimerization activityAlpha-1B adrenergic receptorHomo sapiens (human)
alpha1-adrenergic receptor activityAlpha-1B adrenergic receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (37)

Processvia Protein(s)Taxonomy
plasma membrane5-hydroxytryptamine receptor 1AHomo sapiens (human)
synapse5-hydroxytryptamine receptor 1AHomo sapiens (human)
plasma membrane5-hydroxytryptamine receptor 1AHomo sapiens (human)
dendrite5-hydroxytryptamine receptor 1AHomo sapiens (human)
plasma membraneAlpha-1D adrenergic receptorHomo sapiens (human)
plasma membraneAlpha-1D adrenergic receptorHomo sapiens (human)
nucleusAlpha-1A adrenergic receptorHomo sapiens (human)
nucleoplasmAlpha-1A adrenergic receptorHomo sapiens (human)
cytoplasmAlpha-1A adrenergic receptorHomo sapiens (human)
cytosolAlpha-1A adrenergic receptorHomo sapiens (human)
plasma membraneAlpha-1A adrenergic receptorHomo sapiens (human)
caveolaAlpha-1A adrenergic receptorHomo sapiens (human)
nuclear membraneAlpha-1A adrenergic receptorHomo sapiens (human)
intracellular membrane-bounded organelleAlpha-1A adrenergic receptorHomo sapiens (human)
plasma membraneAlpha-1A adrenergic receptorHomo sapiens (human)
nucleusAlpha-1B adrenergic receptorHomo sapiens (human)
cytoplasmAlpha-1B adrenergic receptorHomo sapiens (human)
plasma membraneAlpha-1B adrenergic receptorHomo sapiens (human)
caveolaAlpha-1B adrenergic receptorHomo sapiens (human)
nuclear membraneAlpha-1B adrenergic receptorHomo sapiens (human)
plasma membraneAlpha-1B adrenergic receptorHomo sapiens (human)
cytoplasmCytochrome P450 3A4Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 3A4Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 3A4Homo sapiens (human)
plasma membrane5-hydroxytryptamine receptor 1AHomo sapiens (human)
synapse5-hydroxytryptamine receptor 1AHomo sapiens (human)
plasma membrane5-hydroxytryptamine receptor 1AHomo sapiens (human)
dendrite5-hydroxytryptamine receptor 1AHomo sapiens (human)
cytoplasmAlpha-2A adrenergic receptorHomo sapiens (human)
plasma membraneAlpha-2A adrenergic receptorHomo sapiens (human)
basolateral plasma membraneAlpha-2A adrenergic receptorHomo sapiens (human)
neuronal cell bodyAlpha-2A adrenergic receptorHomo sapiens (human)
axon terminusAlpha-2A adrenergic receptorHomo sapiens (human)
presynaptic active zone membraneAlpha-2A adrenergic receptorHomo sapiens (human)
dopaminergic synapseAlpha-2A adrenergic receptorHomo sapiens (human)
postsynaptic density membraneAlpha-2A adrenergic receptorHomo sapiens (human)
glutamatergic synapseAlpha-2A adrenergic receptorHomo sapiens (human)
GABA-ergic synapseAlpha-2A adrenergic receptorHomo sapiens (human)
receptor complexAlpha-2A adrenergic receptorHomo sapiens (human)
plasma membraneAlpha-2A adrenergic receptorHomo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2C9 Homo sapiens (human)
plasma membraneCytochrome P450 2C9 Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C9 Homo sapiens (human)
cytoplasmCytochrome P450 2C9 Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C9 Homo sapiens (human)
Golgi membraneD(2) dopamine receptorHomo sapiens (human)
acrosomal vesicleD(2) dopamine receptorHomo sapiens (human)
plasma membraneD(2) dopamine receptorHomo sapiens (human)
ciliumD(2) dopamine receptorHomo sapiens (human)
lateral plasma membraneD(2) dopamine receptorHomo sapiens (human)
endocytic vesicleD(2) dopamine receptorHomo sapiens (human)
axonD(2) dopamine receptorHomo sapiens (human)
dendriteD(2) dopamine receptorHomo sapiens (human)
synaptic vesicle membraneD(2) dopamine receptorHomo sapiens (human)
sperm flagellumD(2) dopamine receptorHomo sapiens (human)
dendritic spineD(2) dopamine receptorHomo sapiens (human)
perikaryonD(2) dopamine receptorHomo sapiens (human)
axon terminusD(2) dopamine receptorHomo sapiens (human)
postsynaptic membraneD(2) dopamine receptorHomo sapiens (human)
ciliary membraneD(2) dopamine receptorHomo sapiens (human)
non-motile ciliumD(2) dopamine receptorHomo sapiens (human)
dopaminergic synapseD(2) dopamine receptorHomo sapiens (human)
GABA-ergic synapseD(2) dopamine receptorHomo sapiens (human)
G protein-coupled receptor complexD(2) dopamine receptorHomo sapiens (human)
glutamatergic synapseD(2) dopamine receptorHomo sapiens (human)
presynaptic membraneD(2) dopamine receptorHomo sapiens (human)
plasma membraneD(2) dopamine receptorHomo sapiens (human)
cytosolAlpha-2B adrenergic receptorHomo sapiens (human)
plasma membraneAlpha-2B adrenergic receptorHomo sapiens (human)
cell surfaceAlpha-2B adrenergic receptorHomo sapiens (human)
intracellular membrane-bounded organelleAlpha-2B adrenergic receptorHomo sapiens (human)
plasma membraneAlpha-2B adrenergic receptorHomo sapiens (human)
nucleusAlpha-1A adrenergic receptorBos taurus (cattle)
cytoplasmAlpha-1A adrenergic receptorBos taurus (cattle)
plasma membraneAlpha-1A adrenergic receptorBos taurus (cattle)
caveolaAlpha-1A adrenergic receptorBos taurus (cattle)
nuclear membraneAlpha-1A adrenergic receptorBos taurus (cattle)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
cytoplasmAlpha-2C adrenergic receptorHomo sapiens (human)
endosomeAlpha-2C adrenergic receptorHomo sapiens (human)
plasma membraneAlpha-2C adrenergic receptorHomo sapiens (human)
plasma membraneAlpha-2C adrenergic receptorHomo sapiens (human)
plasma membraneAlpha-1D adrenergic receptorHomo sapiens (human)
plasma membraneAlpha-1D adrenergic receptorHomo sapiens (human)
Golgi membraneAdenosine receptor A2aRattus norvegicus (Norway rat)
nucleusAlpha-1A adrenergic receptorHomo sapiens (human)
nucleoplasmAlpha-1A adrenergic receptorHomo sapiens (human)
cytoplasmAlpha-1A adrenergic receptorHomo sapiens (human)
cytosolAlpha-1A adrenergic receptorHomo sapiens (human)
plasma membraneAlpha-1A adrenergic receptorHomo sapiens (human)
caveolaAlpha-1A adrenergic receptorHomo sapiens (human)
nuclear membraneAlpha-1A adrenergic receptorHomo sapiens (human)
intracellular membrane-bounded organelleAlpha-1A adrenergic receptorHomo sapiens (human)
plasma membraneAlpha-1A adrenergic receptorHomo sapiens (human)
nucleusAlpha-1B adrenergic receptorHomo sapiens (human)
cytoplasmAlpha-1B adrenergic receptorHomo sapiens (human)
plasma membraneAlpha-1B adrenergic receptorHomo sapiens (human)
caveolaAlpha-1B adrenergic receptorHomo sapiens (human)
nuclear membraneAlpha-1B adrenergic receptorHomo sapiens (human)
plasma membraneAlpha-1B adrenergic receptorHomo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (244)

Assay IDTitleYearJournalArticle
AID36747Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay2003Journal of medicinal chemistry, Apr-10, Volume: 46, Issue:8
1,3-dioxolane-based ligands as a novel class of alpha1-adrenoceptor antagonists.
AID603870Binding affinity to adrenergic Alpha-1D receptor2011European journal of medicinal chemistry, Jul, Volume: 46, Issue:7
Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for α₁-adrenoceptor subtypes.
AID603868Binding affinity to adrenergic alpha1A receptor2011European journal of medicinal chemistry, Jul, Volume: 46, Issue:7
Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for α₁-adrenoceptor subtypes.
AID521220Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay2007Nature chemical biology, May, Volume: 3, Issue:5
Chemical genetics reveals a complex functional ground state of neural stem cells.
AID234949Selectivity given as ratio of pKb value against Alpha-1D receptor to pKb value against alpha1A receptor in rat2003Journal of medicinal chemistry, Apr-10, Volume: 46, Issue:8
1,3-dioxolane-based ligands as a novel class of alpha1-adrenoceptor antagonists.
AID63792Antagonistic affinity against rat striatum Dopamine receptor D21998Bioorganic & medicinal chemistry letters, Jun-02, Volume: 8, Issue:11
Search for alpha 1-adrenoceptor subtypes selective antagonists: design, synthesis and biological activity of cystazosin, an alpha 1D-adrenoceptor antagonist.
AID234953Selectivity over human alpha-1d/alpha-1a receptor2003Journal of medicinal chemistry, Apr-10, Volume: 46, Issue:8
1,3-dioxolane-based ligands as a novel class of alpha1-adrenoceptor antagonists.
AID234954Selectivity over human alpha-1d/alpha-1b receptor2003Journal of medicinal chemistry, Apr-10, Volume: 46, Issue:8
1,3-dioxolane-based ligands as a novel class of alpha1-adrenoceptor antagonists.
AID37478Binding affinity was tested on human Alpha-1B adrenergic receptor1997Journal of medicinal chemistry, Apr-25, Volume: 40, Issue:9
Pharmacological options in the treatment of benign prostatic hyperplasia.
AID35151Antagonistic affinity against Alpha-1B adrenergic receptor was determined in isolated spleen tissue from rat1998Bioorganic & medicinal chemistry letters, Jun-02, Volume: 8, Issue:11
Search for alpha 1-adrenoceptor subtypes selective antagonists: design, synthesis and biological activity of cystazosin, an alpha 1D-adrenoceptor antagonist.
AID766560Selectivity ratio of Ki for alpha-1D adrenoreceptor in Sprague-Dawley rat thoracic aorta to Ki for alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens2013Journal of medicinal chemistry, Aug-22, Volume: 56, Issue:16
6-methoxy-7-benzofuranoxy and 6-methoxy-7-indolyloxy analogues of 2-[2-(2,6-Dimethoxyphenoxy)ethyl]aminomethyl-1,4-benzodioxane (WB4101):1 discovery of a potent and selective α1D-adrenoceptor antagonist.
AID35608Antagonistic affinity against Alpha-1D adrenergic receptor was determined in isolated thoracic aorta from rat1998Bioorganic & medicinal chemistry letters, Jun-02, Volume: 8, Issue:11
Search for alpha 1-adrenoceptor subtypes selective antagonists: design, synthesis and biological activity of cystazosin, an alpha 1D-adrenoceptor antagonist.
AID37357Affinity constant towards human recombinant Alpha-1B adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay2003Journal of medicinal chemistry, Apr-10, Volume: 46, Issue:8
1,3-dioxolane-based ligands as a novel class of alpha1-adrenoceptor antagonists.
AID35502Antagonistic affinity against native rat cortex Alpha-2 adrenergic receptor1998Bioorganic & medicinal chemistry letters, Jun-02, Volume: 8, Issue:11
Search for alpha 1-adrenoceptor subtypes selective antagonists: design, synthesis and biological activity of cystazosin, an alpha 1D-adrenoceptor antagonist.
AID36909Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat1998Bioorganic & medicinal chemistry letters, Jun-02, Volume: 8, Issue:11
Search for alpha 1-adrenoceptor subtypes selective antagonists: design, synthesis and biological activity of cystazosin, an alpha 1D-adrenoceptor antagonist.
AID766559Selectivity ratio of Ki for alpha-1D adrenoreceptor in Sprague-Dawley rat thoracic aorta to Ki for alpha-1B adrenoreceptor in Sprague-Dawley rat spleen2013Journal of medicinal chemistry, Aug-22, Volume: 56, Issue:16
6-methoxy-7-benzofuranoxy and 6-methoxy-7-indolyloxy analogues of 2-[2-(2,6-Dimethoxyphenoxy)ethyl]aminomethyl-1,4-benzodioxane (WB4101):1 discovery of a potent and selective α1D-adrenoceptor antagonist.
AID603869Binding affinity to adrenergic Alpha-1B receptor2011European journal of medicinal chemistry, Jul, Volume: 46, Issue:7
Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for α₁-adrenoceptor subtypes.
AID234950Selectivity given as ratio of pKb value against Alpha-1D receptor to pKb value against Alpha-1B receptor in rat2003Journal of medicinal chemistry, Apr-10, Volume: 46, Issue:8
1,3-dioxolane-based ligands as a novel class of alpha1-adrenoceptor antagonists.
AID234948Selectivity given as ratio of pKb value against alpha1A receptor to pKb value against alpha-1B receptor in rat2003Journal of medicinal chemistry, Apr-10, Volume: 46, Issue:8
1,3-dioxolane-based ligands as a novel class of alpha1-adrenoceptor antagonists.
AID766566Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis2013Journal of medicinal chemistry, Aug-22, Volume: 56, Issue:16
6-methoxy-7-benzofuranoxy and 6-methoxy-7-indolyloxy analogues of 2-[2-(2,6-Dimethoxyphenoxy)ethyl]aminomethyl-1,4-benzodioxane (WB4101):1 discovery of a potent and selective α1D-adrenoceptor antagonist.
AID35468Binding affinity was tested on human Alpha-1D adrenergic receptor1997Journal of medicinal chemistry, Apr-25, Volume: 40, Issue:9
Pharmacological options in the treatment of benign prostatic hyperplasia.
AID36753Binding affinity was tested on human Alpha-1A adrenergic receptor1997Journal of medicinal chemistry, Apr-25, Volume: 40, Issue:9
Pharmacological options in the treatment of benign prostatic hyperplasia.
AID3920Antagonistic affinity against cloned human 5-hydroxytryptamine 1A receptor1998Bioorganic & medicinal chemistry letters, Jun-02, Volume: 8, Issue:11
Search for alpha 1-adrenoceptor subtypes selective antagonists: design, synthesis and biological activity of cystazosin, an alpha 1D-adrenoceptor antagonist.
AID36124pA2 for Alpha-1 adrenergic receptor from human prostate.1997Journal of medicinal chemistry, Apr-25, Volume: 40, Issue:9
Pharmacological options in the treatment of benign prostatic hyperplasia.
AID766565Antagonist activity at alpha-1B adrenoreceptor in Sprague-Dawley rat spleen assessed as inhibition of phenylephrine-induced tissue contraction after 30 mins by Schild plot analysis2013Journal of medicinal chemistry, Aug-22, Volume: 56, Issue:16
6-methoxy-7-benzofuranoxy and 6-methoxy-7-indolyloxy analogues of 2-[2-(2,6-Dimethoxyphenoxy)ethyl]aminomethyl-1,4-benzodioxane (WB4101):1 discovery of a potent and selective α1D-adrenoceptor antagonist.
AID35460Affinity constant towards human recombinant Alpha-1D adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay2003Journal of medicinal chemistry, Apr-10, Volume: 46, Issue:8
1,3-dioxolane-based ligands as a novel class of alpha1-adrenoceptor antagonists.
AID234952Selectivity over human alpha-1a/alpha-1b receptor2003Journal of medicinal chemistry, Apr-10, Volume: 46, Issue:8
1,3-dioxolane-based ligands as a novel class of alpha1-adrenoceptor antagonists.
AID176134Decrease in hippocampal level of 5-HT at preinjection of 5 mg/kg, sc1993Journal of medicinal chemistry, May-14, Volume: 36, Issue:10
(S)-N-tert-butyl-3-(4-(2-methoxyphenyl)-piperazin-1-yl)-2-phenylpropanamide [(S)-WAY-100135]: a selective antagonist at presynaptic and postsynaptic 5-HT1A receptors.
AID35738Inhibition of (-)-noradrenaline-induced contraction of rat thoracic aorta (Alpha-1D adrenergic receptor)2003Journal of medicinal chemistry, Apr-10, Volume: 46, Issue:8
1,3-dioxolane-based ligands as a novel class of alpha1-adrenoceptor antagonists.
AID35165Inhibition of (-)-phenylephrine-induced contraction of rat spleen (Alpha-1B adrenergic receptor )2003Journal of medicinal chemistry, Apr-10, Volume: 46, Issue:8
1,3-dioxolane-based ligands as a novel class of alpha1-adrenoceptor antagonists.
AID766558Binding affinity to human 5-HT1A receptor2013Journal of medicinal chemistry, Aug-22, Volume: 56, Issue:16
6-methoxy-7-benzofuranoxy and 6-methoxy-7-indolyloxy analogues of 2-[2-(2,6-Dimethoxyphenoxy)ethyl]aminomethyl-1,4-benzodioxane (WB4101):1 discovery of a potent and selective α1D-adrenoceptor antagonist.
AID766564Antagonist activity at alpha-1D adrenoreceptor in Sprague-Dawley rat thoracic aorta assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis2013Journal of medicinal chemistry, Aug-22, Volume: 56, Issue:16
6-methoxy-7-benzofuranoxy and 6-methoxy-7-indolyloxy analogues of 2-[2-(2,6-Dimethoxyphenoxy)ethyl]aminomethyl-1,4-benzodioxane (WB4101):1 discovery of a potent and selective α1D-adrenoceptor antagonist.
AID219628Inhibition of (-)-noradrenaline-induced contraction of rat prostatic vas deferens (alpha1A receptor)2003Journal of medicinal chemistry, Apr-10, Volume: 46, Issue:8
1,3-dioxolane-based ligands as a novel class of alpha1-adrenoceptor antagonists.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
AID36868Inhibition of [3H]WB-4101 binding to alpha-1-adrenergic receptor from rat cerebral cortex membranes1983Journal of medicinal chemistry, Feb, Volume: 26, Issue:2
Buspirone analogues. 1. Structure-activity relationships in a series of N-aryl- and heteroarylpiperazine derivatives.
AID465068Agonist activity at human recombinant 5HT1A receptor expressed in human HeLa cells by [35S]GTPgammaS binding assay relative to serotonin2010Bioorganic & medicinal chemistry letters, Mar-15, Volume: 20, Issue:6
Discovery of a new series of 5-HT1A receptor agonists.
AID1459193Displacement of [3H]8-OH-DPAT from recombinant human 5HT1A receptor expressed in human HeLa cell membranes after 30 mins by liquid scintillation counting method
AID391753Displacement of [3H]prazosin from human cloned alpha1D adrenoceptor expressed in CHO cells2008Journal of medicinal chemistry, Oct-23, Volume: 51, Issue:20
Structure-activity relationships in 1,4-benzodioxan-related compounds. 9. From 1,4-benzodioxane to 1,4-dioxane ring as a promising template of novel alpha1D-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents.
AID391757Antagonist activity at Alpha-1D adrenoceptor in Wistar rat thoracic aorta assessed as inhibition of (-)-noradrenaline-induced contraction after 30 mins2008Journal of medicinal chemistry, Oct-23, Volume: 51, Issue:20
Structure-activity relationships in 1,4-benzodioxan-related compounds. 9. From 1,4-benzodioxane to 1,4-dioxane ring as a promising template of novel alpha1D-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents.
AID510560Agonist activity at human cloned 5HT1A receptor expressed in human HeLa cells assessed as stimulation of [35S]GTPgammaS binding after 20 mins by liquid scintillation counting relative to maximal 5HT response2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.
AID36911Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor2002Journal of medicinal chemistry, Apr-11, Volume: 45, Issue:8
Structure-activity relationships in 1,4-benzodioxan-related compounds. 7. Selectivity of 4-phenylchroman analogues for alpha(1)-adrenoreceptor subtypes.
AID510401Selectivity for adrenergic alpha1A receptor in Wistar rat prostatic vas deferens over adrenergic Alpha-1D receptor in Wistar rat thoracic aorta2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.
AID185742Maximum agonist effect (% effect) expressed relative to 8-hydroxy-DPAT (100%)1995Journal of medicinal chemistry, Sep-29, Volume: 38, Issue:20
Characterization of potent and selective antagonists at postsynaptic 5-HT1A receptors in a series of N4-substituted arylpiperazines.
AID510397Antagonist activity at adrenergic Alpha-1B receptor in Wistar rat spleen assessed as inhibition of (-)-phenylepinephrine-induced tissue contraction treated 30 mins before (-)phenylepinephrine challenge2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.
AID4411Binding affinity of a compound to rat brain 5-hydroxytryptamine 1A (serotonin) receptor assayed by radiolabeled [3H]-8-OH-DPAT ligand displacement1996Journal of medicinal chemistry, Jan-05, Volume: 39, Issue:1
Binding of arylpiperazines, (aryloxy)propanolamines, and tetrahydropyridylindoles to the 5-HT1A receptor: contribution of the molecular lipophilicity potential to three-dimensional quantitative structure-affinity relationship models.
AID724007Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins2013Journal of medicinal chemistry, Jan-24, Volume: 56, Issue:2
Structure-activity relationships in 1,4-benzodioxan-related compounds. 11. (1) reversed enantioselectivity of 1,4-dioxane derivatives in α1-adrenergic and 5-HT1A receptor binding sites recognition.
AID465065Inhibition of noradrenaline-induced contraction in rat spleen2010Bioorganic & medicinal chemistry letters, Mar-15, Volume: 20, Issue:6
Discovery of a new series of 5-HT1A receptor agonists.
AID36745Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor1999Journal of medicinal chemistry, Oct-07, Volume: 42, Issue:20
WB 4101-related compounds. 2. Role of the ethylene chain separating amine and phenoxy units on the affinity for alpha(1)-adrenoreceptor subtypes and 5-HT(1A) receptors.
AID240448The maximal stimulation of [35S]GTP-gamma-S, binding (Emax) against the 5-hydroxytryptamine 1A receptor2005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
1,2,4-Benzothiadiazine derivatives as alpha1 and 5-HT1A receptor ligands.
AID35614In vitro functional activity at Alpha-1D adrenergic receptor in rat aorta2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Two novel and potent 3-[(o-methoxyphenyl)piperazinylethyl]-5-phenylthien.
AID4416Binding affinity at 5-hydroxytryptamine 1A receptor1995Journal of medicinal chemistry, Sep-29, Volume: 38, Issue:20
Characterization of potent and selective antagonists at postsynaptic 5-HT1A receptors in a series of N4-substituted arylpiperazines.
AID692052Antagonist activity at adrenergic alpha 1D receptor in rat thoracic aorta assessed as inhibition of noradrenaline-induced contraction after 1 hr2011European journal of medicinal chemistry, Jul, Volume: 46, Issue:7
Discovery of LASSBio-772, a 1,3-benzodioxole N-phenylpiperazine derivative with potent alpha 1A/D-adrenergic receptor blocking properties.
AID1337883Displacement of [3H]prazosin from recombinant human alpha1d adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
AID238558Binding affinity for human Alpha-1B adrenergic receptor2005Journal of medicinal chemistry, Apr-21, Volume: 48, Issue:8
Synthesis and structure-activity relationship of fluoro analogues of 8-{2-[4-(4-methoxyphenyl)piperazin-1yl]ethyl}-8-azaspiro[4.5]decane-7,9-dione as selective alpha(1d)-adrenergic receptor antagonists.
AID643008Displacement of [3H]-OH-DPAT from human recombinant 5HT1A receptor expressed in HeLa cells after 30 mins by liquid scintillation counting2012Journal of medicinal chemistry, Jan-12, Volume: 55, Issue:1
Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic α₁- and serotonine 5-HT1A receptors.
AID643005Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting2012Journal of medicinal chemistry, Jan-12, Volume: 55, Issue:1
Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic α₁- and serotonine 5-HT1A receptors.
AID37358Affinity constant on CHO cells expressing Human recombinant Alpha-1B adrenergic receptor2002Journal of medicinal chemistry, Apr-11, Volume: 45, Issue:8
Structure-activity relationships in 1,4-benzodioxan-related compounds. 7. Selectivity of 4-phenylchroman analogues for alpha(1)-adrenoreceptor subtypes.
AID239889Antagonist potency against the alpha-1B adrenergic receptor determined in isolated rat spleen2005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
1,2,4-Benzothiadiazine derivatives as alpha1 and 5-HT1A receptor ligands.
AID3934Binding affinity at human cloned 5-hydroxytryptamine 1A receptor expressed in HeLa cells by [3H]8-hydroxy-2-(di-n-propylamino)tetraline displacement.1998Journal of medicinal chemistry, Nov-19, Volume: 41, Issue:24
Design, synthesis, and biological activity of prazosin-related antagonists. Role of the piperazine and furan units of prazosin on the selectivity for alpha1-adrenoreceptor subtypes.
AID35734Alpha-1D adrenergic receptor subtype blocking activity (antagonism) against (-)-noradrenaline-induced contraction of rat thoracic aorta.1999Journal of medicinal chemistry, Oct-07, Volume: 42, Issue:20
WB 4101-related compounds. 2. Role of the ethylene chain separating amine and phenoxy units on the affinity for alpha(1)-adrenoreceptor subtypes and 5-HT(1A) receptors.
AID1337886Agonist activity at recombinant human 5-HT1A receptor expressed in HeLa cell membranes assessed as induction of [35S]GTPgammaS binding up to 10 uM preincubated for 20 mins followed by [35S]GTPgammaS addition measured after 30 mins by liquid scintillation
AID510389Displacement [3H]prazosin of human recombinant Alpha-1B adrenergic receptor expressed in CHO cells by rapid filtration technique2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.
AID1337881Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
AID239890Antagonist potency against the alpha-1D adrenergic receptor was determined in isolated rat thoracic aorta2005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
1,2,4-Benzothiadiazine derivatives as alpha1 and 5-HT1A receptor ligands.
AID36901In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.2004Journal of medicinal chemistry, Apr-08, Volume: 47, Issue:8
Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.
AID37203In vitro binding affinity at human Alpha-1B adrenergic receptor.2003Journal of medicinal chemistry, Jul-03, Volume: 46, Issue:14
New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.
AID35459Displacement of [3H]prazosin from human cloned Alpha-1D adrenergic receptor1999Journal of medicinal chemistry, Oct-07, Volume: 42, Issue:20
WB 4101-related compounds. 2. Role of the ethylene chain separating amine and phenoxy units on the affinity for alpha(1)-adrenoreceptor subtypes and 5-HT(1A) receptors.
AID244165Selectivity towards alpha 1D and alpha 1A adrenergic receptors2005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
1,2,4-Benzothiadiazine derivatives as alpha1 and 5-HT1A receptor ligands.
AID177895Inhibition of conditioned avoidance response (CAR) in fasted male Sprague-Dawley rats.1983Journal of medicinal chemistry, Feb, Volume: 26, Issue:2
Buspirone analogues. 1. Structure-activity relationships in a series of N-aryl- and heteroarylpiperazine derivatives.
AID1593197Displacement of [3H]Prazosin from human recombinant alpha 1D adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
AID465067Selectivity ratio of pKi for human 5-HT1A receptor to pKi for human alpha1 adrenergic receptor2010Bioorganic & medicinal chemistry letters, Mar-15, Volume: 20, Issue:6
Discovery of a new series of 5-HT1A receptor agonists.
AID63790Displacement of [3H]spiperone from rat brain Dopamine receptor D21999Journal of medicinal chemistry, Oct-07, Volume: 42, Issue:20
WB 4101-related compounds. 2. Role of the ethylene chain separating amine and phenoxy units on the affinity for alpha(1)-adrenoreceptor subtypes and 5-HT(1A) receptors.
AID465063Displacement of [3H]8-OH-DPAT from human 5-HT1A receptor expressed in human HeLa cells2010Bioorganic & medicinal chemistry letters, Mar-15, Volume: 20, Issue:6
Discovery of a new series of 5-HT1A receptor agonists.
AID3505Fraction involved in salt bridge interactions with Asp3:11 part of the 5-hydroxytryptamine 1A receptor2004Journal of medicinal chemistry, Apr-08, Volume: 47, Issue:8
Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.
AID643012Agonist activity at human recombinant 5HT1A receptor expressed in HeLa cells preincubated for 20 mins by [35S]GTPgammaS binding assay2012Journal of medicinal chemistry, Jan-12, Volume: 55, Issue:1
Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic α₁- and serotonine 5-HT1A receptors.
AID510391Displacement [3H]8-OH-DPAT of human cloned 5HT1A receptor expressed in human HeLa cells by rapid filtration technique2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.
AID35320Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1D adrenergic receptor (n >= 2)1998Journal of medicinal chemistry, Apr-09, Volume: 41, Issue:8
4-Amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6, 7-dimethoxyquinazoline (L-765,314): a potent and selective alpha1b adrenergic receptor antagonist.
AID35156In vitro functional activity at Alpha-1B adrenergic receptor in rat spleen2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Two novel and potent 3-[(o-methoxyphenyl)piperazinylethyl]-5-phenylthien.
AID37034In vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferens2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Two novel and potent 3-[(o-methoxyphenyl)piperazinylethyl]-5-phenylthien.
AID35629Binding affinity at native Alpha-2 adrenergic receptor in rat cerebral cortex by [3H]rauwolscine displacement.1998Journal of medicinal chemistry, Nov-19, Volume: 41, Issue:24
Design, synthesis, and biological activity of prazosin-related antagonists. Role of the piperazine and furan units of prazosin on the selectivity for alpha1-adrenoreceptor subtypes.
AID37059Fraction involved in salt bridge interactions with Asp3:11 part of the alpha-1B adrenergic receptor2004Journal of medicinal chemistry, Apr-08, Volume: 47, Issue:8
Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.
AID228345Ki ratio measured as the Ki values of dopamine receptor to that of 5-hydroxytryptamine 1A receptor1995Journal of medicinal chemistry, Sep-29, Volume: 38, Issue:20
Characterization of potent and selective antagonists at postsynaptic 5-HT1A receptors in a series of N4-substituted arylpiperazines.
AID1337882Displacement of [3H]prazosin from recombinant human alpha1b adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
AID37219Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1B adrenergic receptor (n >= 2)1998Journal of medicinal chemistry, Apr-09, Volume: 41, Issue:8
4-Amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6, 7-dimethoxyquinazoline (L-765,314): a potent and selective alpha1b adrenergic receptor antagonist.
AID36606Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor (n >= 2)1998Journal of medicinal chemistry, Apr-09, Volume: 41, Issue:8
4-Amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6, 7-dimethoxyquinazoline (L-765,314): a potent and selective alpha1b adrenergic receptor antagonist.
AID36484Binding affinity for human Alpha-1A adrenergic receptor2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Two novel and potent 3-[(o-methoxyphenyl)piperazinylethyl]-5-phenylthien.
AID239068Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive2005Bioorganic & medicinal chemistry letters, Feb-01, Volume: 15, Issue:3
Pharmacophore identification of alpha(1A)-adrenoceptor antagonists.
AID238354Binding affinity for rat Dopamine receptor D32005Journal of medicinal chemistry, Apr-21, Volume: 48, Issue:8
Synthesis and structure-activity relationship of fluoro analogues of 8-{2-[4-(4-methoxyphenyl)piperazin-1yl]ethyl}-8-azaspiro[4.5]decane-7,9-dione as selective alpha(1d)-adrenergic receptor antagonists.
AID37206Binding affinity towards human Alpha-1B adrenergic receptor2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Two novel and potent 3-[(o-methoxyphenyl)piperazinylethyl]-5-phenylthien.
AID391754Displacement of [3H]8-OH-DPAT from human cloned 5HT1A receptor expressed in human HeLa cells2008Journal of medicinal chemistry, Oct-23, Volume: 51, Issue:20
Structure-activity relationships in 1,4-benzodioxan-related compounds. 9. From 1,4-benzodioxane to 1,4-dioxane ring as a promising template of novel alpha1D-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents.
AID643013Agonist activity at human recombinant 5HT1A receptor expressed in HeLa cells preincubated for 20 mins by [35S]GTPgammaS binding assay relative to 8-OH-DPAT2012Journal of medicinal chemistry, Jan-12, Volume: 55, Issue:1
Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic α₁- and serotonine 5-HT1A receptors.
AID36482In vitro binding affinity at human Alpha-1A adrenergic receptor.2003Journal of medicinal chemistry, Jul-03, Volume: 46, Issue:14
New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.
AID1459194Agonist activity at recombinant human 5HT1A receptor expressed in human HeLa cell membranes assessed as stimulation of [35S]GTPgammaS binding preincubated for 20 mins followed by [35S]GTPgammaS addition measured after 30 mins by liquid scintillation count
AID465069Agonist activity at human recombinant 5HT1A receptor expressed in human HeLa cells by [35S]GTPgammaS binding assay2010Bioorganic & medicinal chemistry letters, Mar-15, Volume: 20, Issue:6
Discovery of a new series of 5-HT1A receptor agonists.
AID244164Selectivity towards alpha 1B and alpha 1A adrenergic receptors2005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
1,2,4-Benzothiadiazine derivatives as alpha1 and 5-HT1A receptor ligands.
AID36458Binding affinity towards bovine Alpha-1A adrenergic receptor2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Two novel and potent 3-[(o-methoxyphenyl)piperazinylethyl]-5-phenylthien.
AID3888Agonist efficacy on 5-hydroxytryptamine 1A receptor subtype1999Journal of medicinal chemistry, Oct-07, Volume: 42, Issue:20
WB 4101-related compounds. 2. Role of the ethylene chain separating amine and phenoxy units on the affinity for alpha(1)-adrenoreceptor subtypes and 5-HT(1A) receptors.
AID238557Binding affinity for human Alpha-1A adrenergic receptor2005Journal of medicinal chemistry, Apr-21, Volume: 48, Issue:8
Synthesis and structure-activity relationship of fluoro analogues of 8-{2-[4-(4-methoxyphenyl)piperazin-1yl]ethyl}-8-azaspiro[4.5]decane-7,9-dione as selective alpha(1d)-adrenergic receptor antagonists.
AID510392Selectivity for human recombinant adrenergic alpha1A receptor over human recombinant adrenergic Alpha-1D receptor2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.
AID37510Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1B adrenergic receptor1998Journal of medicinal chemistry, Apr-09, Volume: 41, Issue:8
4-Amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6, 7-dimethoxyquinazoline (L-765,314): a potent and selective alpha1b adrenergic receptor antagonist.
AID723786Displacement of [3H]8-OH-DPAT from human recombinant 5HT1A receptor expressed in HeLa cell membranes after 30 mins2013Journal of medicinal chemistry, Jan-24, Volume: 56, Issue:2
Structure-activity relationships in 1,4-benzodioxan-related compounds. 11. (1) reversed enantioselectivity of 1,4-dioxane derivatives in α1-adrenergic and 5-HT1A receptor binding sites recognition.
AID238380Binding affinity for human Dopamine receptor D22005Journal of medicinal chemistry, Apr-21, Volume: 48, Issue:8
Synthesis and structure-activity relationship of fluoro analogues of 8-{2-[4-(4-methoxyphenyl)piperazin-1yl]ethyl}-8-azaspiro[4.5]decane-7,9-dione as selective alpha(1d)-adrenergic receptor antagonists.
AID229636Selectivity ratio towards 5-HT1A receptor compared with other receptors2004Journal of medicinal chemistry, Apr-08, Volume: 47, Issue:8
Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.
AID510395Selectivity for human recombinant adrenergic alpha1 receptor over human cloned 5HT1A receptor2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.
AID36913Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.1998Journal of medicinal chemistry, Nov-19, Volume: 41, Issue:24
Design, synthesis, and biological activity of prazosin-related antagonists. Role of the piperazine and furan units of prazosin on the selectivity for alpha1-adrenoreceptor subtypes.
AID64625Inhibitory activity against methyl-phenidate-induced gnawing at dopamine receptor D2 in rat1995Journal of medicinal chemistry, Sep-29, Volume: 38, Issue:20
Characterization of potent and selective antagonists at postsynaptic 5-HT1A receptors in a series of N4-substituted arylpiperazines.
AID36625Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor2002Journal of medicinal chemistry, Apr-11, Volume: 45, Issue:8
Structure-activity relationships in 1,4-benzodioxan-related compounds. 7. Selectivity of 4-phenylchroman analogues for alpha(1)-adrenoreceptor subtypes.
AID391751Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells2008Journal of medicinal chemistry, Oct-23, Volume: 51, Issue:20
Structure-activity relationships in 1,4-benzodioxan-related compounds. 9. From 1,4-benzodioxane to 1,4-dioxane ring as a promising template of novel alpha1D-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents.
AID37487Binding affinity at human cloned Alpha-1B adrenergic receptor in chinese hamster ovary cells by [3H]prazosin displacement.1998Journal of medicinal chemistry, Nov-19, Volume: 41, Issue:24
Design, synthesis, and biological activity of prazosin-related antagonists. Role of the piperazine and furan units of prazosin on the selectivity for alpha1-adrenoreceptor subtypes.
AID35364Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.1998Journal of medicinal chemistry, Nov-19, Volume: 41, Issue:24
Design, synthesis, and biological activity of prazosin-related antagonists. Role of the piperazine and furan units of prazosin on the selectivity for alpha1-adrenoreceptor subtypes.
AID1459198Selectivity index, ratio of Ki for recombinant human alpha-1d adrenergic receptor expressed in CHO cell membranes to Ki for recombinant human 5HT1A receptor expressed in human HeLa cell membranes
AID36759Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.1998Journal of medicinal chemistry, Nov-19, Volume: 41, Issue:24
Design, synthesis, and biological activity of prazosin-related antagonists. Role of the piperazine and furan units of prazosin on the selectivity for alpha1-adrenoreceptor subtypes.
AID63807Binding affinity at native Dopamine receptor D2 in rat striatum by [3H]spiperone displacement.1998Journal of medicinal chemistry, Nov-19, Volume: 41, Issue:24
Design, synthesis, and biological activity of prazosin-related antagonists. Role of the piperazine and furan units of prazosin on the selectivity for alpha1-adrenoreceptor subtypes.
AID510398Antagonist activity at adrenergic Alpha-1D receptor in Wistar rat thoracic aorta assessed as inhibition of (-)-norepinephrine-induced vasocontraction treated 30 mins before (-)norepinephrine challenge2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.
AID239801Binding affinity for alpha 1d adrenoceptor2005Journal of medicinal chemistry, Jul-28, Volume: 48, Issue:15
Range and sensitivity as descriptors of molecular property spaces in dynamic QSAR analyses.
AID239877Potency against the 5-hydroxytryptamine 1A receptor determined by using [35S]GTP-gamma-S, binding2005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
1,2,4-Benzothiadiazine derivatives as alpha1 and 5-HT1A receptor ligands.
AID510399Selectivity for adrenergic Alpha-1B receptor in Wistar rat spleen over adrenergic alpha1A receptor in Wistar rat prostatic vas deferens2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.
AID35612Antagonism of norepinephrine induced contraction of rat isolated thoracic aorta.1998Journal of medicinal chemistry, Nov-19, Volume: 41, Issue:24
Design, synthesis, and biological activity of prazosin-related antagonists. Role of the piperazine and furan units of prazosin on the selectivity for alpha1-adrenoreceptor subtypes.
AID35592Binding affinity to the adrenergic receptor alpha-1D of rat aorta2004Journal of medicinal chemistry, Apr-08, Volume: 47, Issue:8
Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.
AID35499Displacement of [3H]rauwolscine from rat brain Alpha-2 adrenergic receptor1999Journal of medicinal chemistry, Oct-07, Volume: 42, Issue:20
WB 4101-related compounds. 2. Role of the ethylene chain separating amine and phenoxy units on the affinity for alpha(1)-adrenoreceptor subtypes and 5-HT(1A) receptors.
AID35462Affinity constant on CHO cells expressing Human recombinant Alpha-1D adrenergic receptor2002Journal of medicinal chemistry, Apr-11, Volume: 45, Issue:8
Structure-activity relationships in 1,4-benzodioxan-related compounds. 7. Selectivity of 4-phenylchroman analogues for alpha(1)-adrenoreceptor subtypes.
AID510396Antagonist activity at adrenergic alpha1A receptor in Wistar rat prostatic vas deferens assessed as inhibition of (-)-noradrenaline-induced tissue contraction treated 30 mins before (-)noradrenalin challenge2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.
AID232299Difference in antagonistic potency between functional and radioligand binding assay2002Journal of medicinal chemistry, Apr-11, Volume: 45, Issue:8
Structure-activity relationships in 1,4-benzodioxan-related compounds. 7. Selectivity of 4-phenylchroman analogues for alpha(1)-adrenoreceptor subtypes.
AID723785Agonist activity at human 5HT1A receptor expressed in HeLa cell membranes by [35S]GTPgammaS binding assay2013Journal of medicinal chemistry, Jan-24, Volume: 56, Issue:2
Structure-activity relationships in 1,4-benzodioxan-related compounds. 11. (1) reversed enantioselectivity of 1,4-dioxane derivatives in α1-adrenergic and 5-HT1A receptor binding sites recognition.
AID724005Displacement of [3H]prazosin from human recombinant alpha1D adrenergic receptor expressed in CHO cell membranes after 30 mins2013Journal of medicinal chemistry, Jan-24, Volume: 56, Issue:2
Structure-activity relationships in 1,4-benzodioxan-related compounds. 11. (1) reversed enantioselectivity of 1,4-dioxane derivatives in α1-adrenergic and 5-HT1A receptor binding sites recognition.
AID239941Inhibitory constant value against the 5-hydroxytryptamine 1A receptor2005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
1,2,4-Benzothiadiazine derivatives as alpha1 and 5-HT1A receptor ligands.
AID1337884Displacement of [3H]8-OH-DPAT from recombinant human 5-HT1A receptor expressed in HeLa cell membranes after 30 mins by TopCount liquid scintillation counting method
AID724006Displacement of [3H]prazosin from human recombinant alpha1B adrenergic receptor expressed in CHO cell membranes after 30 mins2013Journal of medicinal chemistry, Jan-24, Volume: 56, Issue:2
Structure-activity relationships in 1,4-benzodioxan-related compounds. 11. (1) reversed enantioselectivity of 1,4-dioxane derivatives in α1-adrenergic and 5-HT1A receptor binding sites recognition.
AID244192Selectivity towards 5-hydroxytryptamine 1A and alpha 1A adrenergic receptors was determined2005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
1,2,4-Benzothiadiazine derivatives as alpha1 and 5-HT1A receptor ligands.
AID184855Minimum effective agonist dose administered subcutaneously1995Journal of medicinal chemistry, Sep-29, Volume: 38, Issue:20
Characterization of potent and selective antagonists at postsynaptic 5-HT1A receptors in a series of N4-substituted arylpiperazines.
AID35601Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1D adrenergic receptor1998Journal of medicinal chemistry, Apr-09, Volume: 41, Issue:8
4-Amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6, 7-dimethoxyquinazoline (L-765,314): a potent and selective alpha1b adrenergic receptor antagonist.
AID510390Displacement [3H]prazosin of human recombinant Alpha-1D adrenergic receptor expressed in CHO cells by rapid filtration technique2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.
AID62868Inhibition of [3H]spiperone binding to dopamine receptor from rat corpus striatal membranes1983Journal of medicinal chemistry, Feb, Volume: 26, Issue:2
Buspirone analogues. 1. Structure-activity relationships in a series of N-aryl- and heteroarylpiperazine derivatives.
AID229640Selectivity ratio towards alpha-1B adrenergic receptor compared with other receptors2004Journal of medicinal chemistry, Apr-08, Volume: 47, Issue:8
Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.
AID5084Displacement of [3H]ketanserin from rat brain 5-hydroxytryptamine 2 receptor1999Journal of medicinal chemistry, Oct-07, Volume: 42, Issue:20
WB 4101-related compounds. 2. Role of the ethylene chain separating amine and phenoxy units on the affinity for alpha(1)-adrenoreceptor subtypes and 5-HT(1A) receptors.
AID229639Selectivity ratio towards alpha-1A adrenergic receptor compared with other receptors2004Journal of medicinal chemistry, Apr-08, Volume: 47, Issue:8
Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.
AID510393Selectivity for human recombinant adrenergic Alpha-1B receptor over human recombinant adrenergic alpha1D receptor2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.
AID1459190Displacement of [3H]prazosin from recombinant human alpha-1b adrenergic receptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
AID185743Maximum antagonist effect (% effect) expressed relative to 8-hydroxy-DPAT (100%)1995Journal of medicinal chemistry, Sep-29, Volume: 38, Issue:20
Characterization of potent and selective antagonists at postsynaptic 5-HT1A receptors in a series of N4-substituted arylpiperazines.
AID36907Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor; ND is No Data2002Journal of medicinal chemistry, Apr-11, Volume: 45, Issue:8
Structure-activity relationships in 1,4-benzodioxan-related compounds. 7. Selectivity of 4-phenylchroman analogues for alpha(1)-adrenoreceptor subtypes.
AID465062Displacement of [3H]prazosin from human Alpha-1D adrenergic receptor expressed in CHO cells2010Bioorganic & medicinal chemistry letters, Mar-15, Volume: 20, Issue:6
Discovery of a new series of 5-HT1A receptor agonists.
AID239799Binding affinity for alpha 1a adrenoceptor2005Journal of medicinal chemistry, Jul-28, Volume: 48, Issue:15
Range and sensitivity as descriptors of molecular property spaces in dynamic QSAR analyses.
AID35152Antagonistic affinity tested against isolated Rat Spleen Alpha-1B adrenergic receptor2002Journal of medicinal chemistry, Apr-11, Volume: 45, Issue:8
Structure-activity relationships in 1,4-benzodioxan-related compounds. 7. Selectivity of 4-phenylchroman analogues for alpha(1)-adrenoreceptor subtypes.
AID1459192Displacement of [3H]prazosin from recombinant human alpha-1d adrenergic receptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
AID35585Fraction involved in salt bridge interactions with Asp3:11 part of the alpha-1D adrenergic receptor2004Journal of medicinal chemistry, Apr-08, Volume: 47, Issue:8
Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.
AID1337885Agonist activity at recombinant human 5-HT1A receptor expressed in HeLa cell membranes assessed as induction of [35S]GTPgammaS binding preincubated for 20 mins followed by [35S]GTPgammaS addition measured after 30 mins by liquid scintillation counting met
AID35595Binding affinity towards rat Alpha-1D adrenergic receptor2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Two novel and potent 3-[(o-methoxyphenyl)piperazinylethyl]-5-phenylthien.
AID230927Selectivity for alpha 1A-Adrenergic receptors compared to 1D-Adrenergic receptors.2003Journal of medicinal chemistry, Jul-03, Volume: 46, Issue:14
New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.
AID37355Displacement of [3H]prazosin from human cloned Alpha-1B adrenergic receptor1999Journal of medicinal chemistry, Oct-07, Volume: 42, Issue:20
WB 4101-related compounds. 2. Role of the ethylene chain separating amine and phenoxy units on the affinity for alpha(1)-adrenoreceptor subtypes and 5-HT(1A) receptors.
AID391752Displacement of [3H]prazosin from human cloned Alpha-1B adrenoceptor expressed in CHO cells2008Journal of medicinal chemistry, Oct-23, Volume: 51, Issue:20
Structure-activity relationships in 1,4-benzodioxan-related compounds. 9. From 1,4-benzodioxane to 1,4-dioxane ring as a promising template of novel alpha1D-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents.
AID238614Binding affinity for human 5-hydroxytryptamine 1A receptor2005Journal of medicinal chemistry, Apr-21, Volume: 48, Issue:8
Synthesis and structure-activity relationship of fluoro analogues of 8-{2-[4-(4-methoxyphenyl)piperazin-1yl]ethyl}-8-azaspiro[4.5]decane-7,9-dione as selective alpha(1d)-adrenergic receptor antagonists.
AID723784Agonist activity at human 5HT1A receptor expressed in HeLa cell membranes by [35S]GTPgammaS binding assay relative to 5-Hydroxytryptamine2013Journal of medicinal chemistry, Jan-24, Volume: 56, Issue:2
Structure-activity relationships in 1,4-benzodioxan-related compounds. 11. (1) reversed enantioselectivity of 1,4-dioxane derivatives in α1-adrenergic and 5-HT1A receptor binding sites recognition.
AID391759Agonist activity at human cloned 5HT1A receptor expressed in HeLa cell membrane assessed as stimulation of [35S]GTPgammaS binding relative to 5-hydroxytryptamine2008Journal of medicinal chemistry, Oct-23, Volume: 51, Issue:20
Structure-activity relationships in 1,4-benzodioxan-related compounds. 9. From 1,4-benzodioxane to 1,4-dioxane ring as a promising template of novel alpha1D-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents.
AID6435Affinity constant on CHO cells expressing Human recombinant 5-hydroxytryptamine receptor 1A2002Journal of medicinal chemistry, Apr-11, Volume: 45, Issue:8
Structure-activity relationships in 1,4-benzodioxan-related compounds. 7. Selectivity of 4-phenylchroman analogues for alpha(1)-adrenoreceptor subtypes.
AID37060Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen2004Journal of medicinal chemistry, Apr-08, Volume: 47, Issue:8
Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.
AID1593198Displacement of [3H]-8-OH-DPAT from human recombinant 5-HT1A receptor expressed in human HeLa cells incubated for 30 mins by radioligand competition binding assay
AID35310Binding affinity towards human Alpha-1D adrenergic receptor2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Two novel and potent 3-[(o-methoxyphenyl)piperazinylethyl]-5-phenylthien.
AID244166Selectivity towards alpha 1D and alpha 1B adrenergic receptors2005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
1,2,4-Benzothiadiazine derivatives as alpha1 and 5-HT1A receptor ligands.
AID36879Fraction involved in salt bridge interactions with Asp3:11 part of the alpha-1A adrenergic receptor2004Journal of medicinal chemistry, Apr-08, Volume: 47, Issue:8
Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.
AID643006Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting2012Journal of medicinal chemistry, Jan-12, Volume: 55, Issue:1
Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic α₁- and serotonine 5-HT1A receptors.
AID643009Antagonist activity at alpha1A adrenoceptor in Wistar rat prostatic vas deferens assessed as inhibition of (-)-noradrenalilne-induced contraction after 30 mins2012Journal of medicinal chemistry, Jan-12, Volume: 55, Issue:1
Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic α₁- and serotonine 5-HT1A receptors.
AID643007Displacement of [3H]prazosin from human recombinant Alpha-1D adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting2012Journal of medicinal chemistry, Jan-12, Volume: 55, Issue:1
Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic α₁- and serotonine 5-HT1A receptors.
AID228344Ki ratio measured as the Ki values of alpha-1 adrenergic receptor to that of 5-hydroxytryptamine 1A receptor1995Journal of medicinal chemistry, Sep-29, Volume: 38, Issue:20
Characterization of potent and selective antagonists at postsynaptic 5-HT1A receptors in a series of N4-substituted arylpiperazines.
AID239800Binding affinity for alpha 1b adrenoceptor2005Journal of medicinal chemistry, Jul-28, Volume: 48, Issue:15
Range and sensitivity as descriptors of molecular property spaces in dynamic QSAR analyses.
AID36898Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor1998Journal of medicinal chemistry, Apr-09, Volume: 41, Issue:8
4-Amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6, 7-dimethoxyquinazoline (L-765,314): a potent and selective alpha1b adrenergic receptor antagonist.
AID36583Induction of ptosis after subcutaneous administration at alpha-1 adrenergic receptor in rat1995Journal of medicinal chemistry, Sep-29, Volume: 38, Issue:20
Characterization of potent and selective antagonists at postsynaptic 5-HT1A receptors in a series of N4-substituted arylpiperazines.
AID510394Selectivity for human recombinant adrenergic Alpha-1B receptor over human recombinant adrenergic alpha1A receptor2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.
AID35474Binding affinity at human cloned Alpha-1D adrenergic receptor in chinese hamster ovary cells by [3H]prazosin displacement.1998Journal of medicinal chemistry, Nov-19, Volume: 41, Issue:24
Design, synthesis, and biological activity of prazosin-related antagonists. Role of the piperazine and furan units of prazosin on the selectivity for alpha1-adrenoreceptor subtypes.
AID182620Compound after subcutaneous administration was evaluated for antagonist activity against hypothermia induced by 8-hydroxy -DPAT in rat1995Journal of medicinal chemistry, Sep-29, Volume: 38, Issue:20
Characterization of potent and selective antagonists at postsynaptic 5-HT1A receptors in a series of N4-substituted arylpiperazines.
AID229641Selectivity ratio towards alpha-1D adrenergic receptor compared with other receptors2004Journal of medicinal chemistry, Apr-08, Volume: 47, Issue:8
Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.
AID391755Antagonist activity at alpha1A adrenoceptor in Wistar rat prostatic vas deferens assessed as inhibition of (-)-noradrenaline-induced contraction after 30 mins2008Journal of medicinal chemistry, Oct-23, Volume: 51, Issue:20
Structure-activity relationships in 1,4-benzodioxan-related compounds. 9. From 1,4-benzodioxane to 1,4-dioxane ring as a promising template of novel alpha1D-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents.
AID35153Antagonism of phenylephrine stimulated contraction of the rat isolated spleen.1998Journal of medicinal chemistry, Nov-19, Volume: 41, Issue:24
Design, synthesis, and biological activity of prazosin-related antagonists. Role of the piperazine and furan units of prazosin on the selectivity for alpha1-adrenoreceptor subtypes.
AID510388Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.
AID35609Antagonistic affinity tested against isolated Rat Thoracic Aorta Alpha-1D adrenergic receptor2002Journal of medicinal chemistry, Apr-11, Volume: 45, Issue:8
Structure-activity relationships in 1,4-benzodioxan-related compounds. 7. Selectivity of 4-phenylchroman analogues for alpha(1)-adrenoreceptor subtypes.
AID35307In vitro binding affinity at human Alpha-1D adrenergic receptor.2003Journal of medicinal chemistry, Jul-03, Volume: 46, Issue:14
New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.
AID37062Dissociation constant against guinea pig spleen alpha-1B adrenergic receptor in vitro was determined2004Journal of medicinal chemistry, Apr-08, Volume: 47, Issue:8
Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.
AID37038Dissociation constant against rat vas deferens alpha-1A adrenergic receptor in vitro was determined2004Journal of medicinal chemistry, Apr-08, Volume: 47, Issue:8
Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.
AID464910Displacement of [3H]prazosin from human Alpha-1B adrenergic receptor expressed in CHO cells2010Bioorganic & medicinal chemistry letters, Mar-15, Volume: 20, Issue:6
Discovery of a new series of 5-HT1A receptor agonists.
AID177716Induction of catalepsy in nonfasted male Sprague-Dawley rats (dose that produced catalepsy in 50% of the animals)1983Journal of medicinal chemistry, Feb, Volume: 26, Issue:2
Buspirone analogues. 1. Structure-activity relationships in a series of N-aryl- and heteroarylpiperazine derivatives.
AID36896Binding affinity towards rat Alpha-1A adrenergic receptor2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Two novel and potent 3-[(o-methoxyphenyl)piperazinylethyl]-5-phenylthien.
AID391758Agonist activity at human cloned 5HT1A receptor expressed in human HeLa cell membrane assessed as stimulation of [35S]GTPgammaS binding2008Journal of medicinal chemistry, Oct-23, Volume: 51, Issue:20
Structure-activity relationships in 1,4-benzodioxan-related compounds. 9. From 1,4-benzodioxane to 1,4-dioxane ring as a promising template of novel alpha1D-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents.
AID465066Inhibition of noradrenaline-induced contraction in rat thoracic aorta2010Bioorganic & medicinal chemistry letters, Mar-15, Volume: 20, Issue:6
Discovery of a new series of 5-HT1A receptor agonists.
AID37039Antagonist activity against Alpha-1A adrenergic receptor (-)-noradrenaline-induced contraction of rat prostatic vas deferens1999Journal of medicinal chemistry, Oct-07, Volume: 42, Issue:20
WB 4101-related compounds. 2. Role of the ethylene chain separating amine and phenoxy units on the affinity for alpha(1)-adrenoreceptor subtypes and 5-HT(1A) receptors.
AID36020In vitro binding affinity towards Alpha-1 adrenergic receptor in rat cortex was determined using [3H]prazosin as radioligand1995Journal of medicinal chemistry, Sep-29, Volume: 38, Issue:20
Characterization of potent and selective antagonists at postsynaptic 5-HT1A receptors in a series of N4-substituted arylpiperazines.
AID35164Antagonism of Alpha-1B adrenergic receptor subtype (-)-phenylephrine-induced contraction of rat spleen1999Journal of medicinal chemistry, Oct-07, Volume: 42, Issue:20
WB 4101-related compounds. 2. Role of the ethylene chain separating amine and phenoxy units on the affinity for alpha(1)-adrenoreceptor subtypes and 5-HT(1A) receptors.
AID510400Selectivity for adrenergic Alpha-1B receptor in Wistar rat spleen over adrenergic alpha1D receptor in Wistar rat thoracic aorta2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.
AID510403Agonist activity at human cloned 5HT1A receptor expressed in human HeLa cells assessed as stimulation of [35S]GTPgammaS binding after 20 mins by liquid scintillation counting2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.
AID1593195Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
AID391756Antagonist activity at alpha1B adrenoceptor in Wistar rat spleen assessed as inhibition of (-)-phenylephrine-induced contraction after 30 mins2008Journal of medicinal chemistry, Oct-23, Volume: 51, Issue:20
Structure-activity relationships in 1,4-benzodioxan-related compounds. 9. From 1,4-benzodioxane to 1,4-dioxane ring as a promising template of novel alpha1D-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents.
AID3823Binding affinity to human 5-hydroxytryptamine 1A receptor was measured using [3H]-8-hydroxy-2-(di-n-propylamine) tetraline [3H]8-OH-DPAT) as radioligand2004Journal of medicinal chemistry, Apr-08, Volume: 47, Issue:8
Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.
AID1459191Displacement of [3H]prazosin from recombinant human alpha-1a adrenergic receptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
AID230050Ratio of MED (agonist) to that of MED (antagonist) values.1995Journal of medicinal chemistry, Sep-29, Volume: 38, Issue:20
Characterization of potent and selective antagonists at postsynaptic 5-HT1A receptors in a series of N4-substituted arylpiperazines.
AID643011Antagonist activity at Alpha-1D adrenoceptor in Wistar rat endothelium denuded thoracic aorta assessed as inhibition of (-)-noradrenalilne-induced contraction after 30 mins2012Journal of medicinal chemistry, Jan-12, Volume: 55, Issue:1
Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic α₁- and serotonine 5-HT1A receptors.
AID239892Antagonist potency against the alpha-1A adrenergic receptor was determined in isolated rat prostatic vas deferens2005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
1,2,4-Benzothiadiazine derivatives as alpha1 and 5-HT1A receptor ligands.
AID1459195Agonist activity at recombinant human 5HT1A receptor expressed in human HeLa cell membranes assessed as stimulation of [35S]GTPgammaS binding up to 10 uM preincubated for 20 mins followed by [35S]GTPgammaS addition measured after 30 mins by liquid scintil
AID4015Binding affinity towards 5-hydroxytryptamine 1A receptor in the rat brain (hippocampus) using [3H]8-OH-DPAT1996Journal of medicinal chemistry, Mar-01, Volume: 39, Issue:5
8-[4-[2-(1,2,3,4-Tetrahydroisoquinolinyl]butyl-8-azaspiro[4.5]decane-7,9-dione: a new 5-HT1A receptor ligand with the same activity profile as buspirone.
AID63816In vitro binding affinity towards Dopamine receptor D2 in rat striatum was determined using [3H]-spiperone as radioligand1995Journal of medicinal chemistry, Sep-29, Volume: 38, Issue:20
Characterization of potent and selective antagonists at postsynaptic 5-HT1A receptors in a series of N4-substituted arylpiperazines.
AID643010Antagonist activity at Alpha-1B receptor in Wistar rat spleen assessed as inhibition of (-)-phenylephrine-induced contraction after 30 mins2012Journal of medicinal chemistry, Jan-12, Volume: 55, Issue:1
Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic α₁- and serotonine 5-HT1A receptors.
AID184856Minimum effective antagonist dose administered subcutaneously1995Journal of medicinal chemistry, Sep-29, Volume: 38, Issue:20
Characterization of potent and selective antagonists at postsynaptic 5-HT1A receptors in a series of N4-substituted arylpiperazines.
AID3899Negative logarithm of concentration required to obtain 50% maximal stimulation of [35S]GTP gamma-S binding to human cloned 5-HT1A receptors of cell membranes from HeLa cells1999Journal of medicinal chemistry, Oct-07, Volume: 42, Issue:20
WB 4101-related compounds. 2. Role of the ethylene chain separating amine and phenoxy units on the affinity for alpha(1)-adrenoreceptor subtypes and 5-HT(1A) receptors.
AID3917Displacement of [3H]8-hydroxy-2-(di-n-propylamino)tetralin from human 5-hydroxytryptamine 1A receptor1999Journal of medicinal chemistry, Oct-07, Volume: 42, Issue:20
WB 4101-related compounds. 2. Role of the ethylene chain separating amine and phenoxy units on the affinity for alpha(1)-adrenoreceptor subtypes and 5-HT(1A) receptors.
AID692055Binding affinity to rabbit aorta adrenergic alpha1A receptor assessed as inhibition of phenylephrine-induced constriction after 30 mins2011European journal of medicinal chemistry, Jul, Volume: 46, Issue:7
Discovery of LASSBio-772, a 1,3-benzodioxole N-phenylpiperazine derivative with potent alpha 1A/D-adrenergic receptor blocking properties.
AID238559Binding affinity for human Alpha-1D adrenergic receptor2005Journal of medicinal chemistry, Apr-21, Volume: 48, Issue:8
Synthesis and structure-activity relationship of fluoro analogues of 8-{2-[4-(4-methoxyphenyl)piperazin-1yl]ethyl}-8-azaspiro[4.5]decane-7,9-dione as selective alpha(1d)-adrenergic receptor antagonists.
AID1593196Displacement of [3H]Prazosin from human recombinant alpha 1B adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
AID35621Dissociation constant against rat aorta alpha-1D adrenergic receptor in vitro was determined2004Journal of medicinal chemistry, Apr-08, Volume: 47, Issue:8
Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.
AID465064Inhibition of noradrenaline-induced contraction in rat prostatic vas deferens2010Bioorganic & medicinal chemistry letters, Mar-15, Volume: 20, Issue:6
Discovery of a new series of 5-HT1A receptor agonists.
AID4718Binding affinity at 5-hydroxytryptamine 1B receptor1995Journal of medicinal chemistry, Sep-29, Volume: 38, Issue:20
Characterization of potent and selective antagonists at postsynaptic 5-HT1A receptors in a series of N4-substituted arylpiperazines.
AID464909Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells2010Bioorganic & medicinal chemistry letters, Mar-15, Volume: 20, Issue:6
Discovery of a new series of 5-HT1A receptor agonists.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347159Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347160Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1345920Rat alpha1D-adrenoceptor (Adrenoceptors)2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Two novel and potent 3-[(o-methoxyphenyl)piperazinylethyl]-5-phenylthien.
AID1345857Rat alpha1A-adrenoceptor (Adrenoceptors)2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Two novel and potent 3-[(o-methoxyphenyl)piperazinylethyl]-5-phenylthien.
AID1346000Human alpha1B-adrenoceptor (Adrenoceptors)2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Two novel and potent 3-[(o-methoxyphenyl)piperazinylethyl]-5-phenylthien.
AID1345615Human 5-HT1A receptor (5-Hydroxytryptamine receptors)1997Life sciences, , Volume: 60, Issue:9
Pharmacological characterization of recombinant human 5-hydroxytryptamine1A receptors using a novel antagonist radioligand, [3H]WAY-100635.
AID1345971Human alpha1D-adrenoceptor (Adrenoceptors)2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Two novel and potent 3-[(o-methoxyphenyl)piperazinylethyl]-5-phenylthien.
AID1345908Human alpha1A-adrenoceptor (Adrenoceptors)2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Two novel and potent 3-[(o-methoxyphenyl)piperazinylethyl]-5-phenylthien.
AID1345908Human alpha1A-adrenoceptor (Adrenoceptors)2001Japanese journal of pharmacology, Jun, Volume: 86, Issue:2
Affinity of serotonin receptor antagonists and agonists to recombinant and native alpha1-adrenoceptor subtypes.
AID1346000Human alpha1B-adrenoceptor (Adrenoceptors)2001Japanese journal of pharmacology, Jun, Volume: 86, Issue:2
Affinity of serotonin receptor antagonists and agonists to recombinant and native alpha1-adrenoceptor subtypes.
AID624210Agonists at Human 5-Hydroxytryptamine receptor 5-HT1A1997Life sciences, , Volume: 60, Issue:9
Pharmacological characterization of recombinant human 5-hydroxytryptamine1A receptors using a novel antagonist radioligand, [3H]WAY-100635.
AID1345971Human alpha1D-adrenoceptor (Adrenoceptors)2001Japanese journal of pharmacology, Jun, Volume: 86, Issue:2
Affinity of serotonin receptor antagonists and agonists to recombinant and native alpha1-adrenoceptor subtypes.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347045Natriuretic polypeptide receptor (hNpr1) antagonism - Pilot counterscreen GloSensor control cell line2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID1347049Natriuretic polypeptide receptor (hNpr1) antagonism - Pilot screen2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID1347059CD47-SIRPalpha protein protein interaction - Alpha assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID1347405qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS LOPAC collection2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1347151Optimization of GU AMC qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID504836Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in human glioma: Validation2002The Journal of biological chemistry, Apr-19, Volume: 277, Issue:16
Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.
AID1347410qHTS for inhibitors of adenylyl cyclases using a fission yeast platform: a pilot screen against the NCATS LOPAC library2019Cellular signalling, 08, Volume: 60A fission yeast platform for heterologous expression of mammalian adenylyl cyclases and high throughput screening.
AID1347050Natriuretic polypeptide receptor (hNpr2) antagonism - Pilot subtype selectivity assay2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID588378qHTS for Inhibitors of ATXN expression: Validation
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347057CD47-SIRPalpha protein protein interaction - LANCE assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID588349qHTS for Inhibitors of ATXN expression: Validation of Cytotoxic Assay
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1347058CD47-SIRPalpha protein protein interaction - HTRF assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (254)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (1.18)18.7374
1990's96 (37.80)18.2507
2000's108 (42.52)29.6817
2010's36 (14.17)24.3611
2020's11 (4.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 19.23

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index19.23 (24.57)
Research Supply Index3.69 (2.92)
Research Growth Index5.29 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (19.23)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials0 (0.00%)5.53%
Reviews2 (0.89%)6.00%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other223 (99.11%)84.16%
Other39 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]